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Epithelial enteroids are an evolving ex vivo model of intestinal physiology and pathophysiology. 
As a model, the enteroids contain limited populations and restricted physiology, but the simpler system 
reduces the variables and confounding complexity of whole tissues or bodies during physiological 
research. Restoring small pieces of complexity in the form of physical traits, differentiation and 
development, or including additional populations allows for greater application of limited model systems. 
Here we describe methods to expand on the original mouse enteroid culture system in the form of 
differentiation of the cultures, generating monolayers, and co-culturing with the sub-mucosal plexus 
population of the enteric nervous system. The development and characterization of new ex vivo modelling 
of the enteroids revealed physiology previously unobserved that redefines our understanding of 
cholinergic signaling in the intestine and potentially other systems. The newly defined nicotinic 
component and increasing complexity of our understanding of cholinergic signaling has implications in 
both our fundamental understanding of cholinergic signaling and secretion in the intestinal epithelium, but 
also in clinical considerations of secretory pathophysiology such as various diarrheal diseases and their 
treatment. The enteroid monolayer model offers a system with which to further interrogate the complex 
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The study of living organisms is endlessly complicated. From small, single base pair changes in 
the DNA code to environmental factors, there are uncountable influences pushing and pulling on all 
organisms every day.  
The study of intestinal physiology is advancing beyond reliance on cancer cell lines and animal 
models to now include the use of stem cell derived organoids, called enteroids and colonoids from various 
species—including humans—or intestinally differentiated induced pluripotent stem cells (iPSC)1–5. These 
are an ex vivo primary culture of normal--or diseased—intestine, derived from stem cells of the small 
intestine (enteroids) or colon (colonoids) which can self-renew indefinitely when provided the appropriate 
growth factors and conditions. The enteroid cultures can be maintained and passed for several years in an 
undifferentiated, crypt-like culture that contains stem cells (LGR5+6–8), transit amplifying cells, and 
Paneth cells. Since the model was first described derived from the mouse small intestine and stomach9,10, 
similar methods have been used to generate ex vivo primary models for many species and organs, from 
the brain, cornea, and inner ear to liver, lung, and all segments of the GI tract11. Such cultures are not 
limited to cells from healthy individuals either, isolation and maintenance of cultures from individuals 
with genetic defects have been used to screen for diseases and drug effectiveness. An example of such 
cultures is the successful generation of cystic fibrosis intestinal enteroids to test various drugs for specific 
patients to improve the quality of life of those with CF12,13.  
 Specifically in the case of the intestine, enteroids have been used to model intestinal ion transport, 
barrier function, and enteric host-pathogen interactions such as rotavirus, cholera, Enterohemorrhagic 
Escherichia coli (EHEC), Clostridium difficile, Human noroviruses, various Salmonella strains, and 
Cryptosporidium infection14,15,24–26,16–23. 
The swift spread of the organoid style model system through such a widespread variety of fields 
and applications is testament to the robustness, application, and versatility of the model. However, even 





3-dimensional, multi-lobed spheroids embedded in a matrix that consists of the stem cell population 
rather than structured mix of undifferentiated and differentiated cells that makes up an adult organ system. 
Another limitation of the system is the inability to form a 2-dimensional culture for access to both the 
apical and basolateral surfaces. As a reductionist model, it lacks the surrounding and supporting cells that 
are constantly providing and receiving assorted signals to maintain the entire organism in response to 
diverse stimuli. Different models have different methods to address these issues in culture and part of the 
following work is in improving the mouse small intestinal enteroid system as a physiological model by 
developing a robust and reproducible 2-dimensional model, inducing differentiation into the assorted cell 
types of the small intestinal villus, and incorporating one of the supporting cell populations, the sub-
mucosal plexus of the enteric nervous system, into culture with the enteroids. 
Once the enteroid system had been altered successfully, characterization of the new culture 
system to validate its use as a model of intestinal physiology was paramount. As such, in addition to 
generating new models, the remainder of the following work consists of the validation of the various 
systems and the characterization of the undefined physiology revealed by the enteroids that was 
















II. Cholinergic Signaling in the Intestinal Epithelium 
The intestine serves as an extended surface area specialized for transfer of nutrients, ions, and 
fluid into and out of the body. Absorption and secretion of various substances occurs differentially both 
segmentally from the duodenum to the distal colon and across the crypt/villus or crypt/surface axes. One 
of the most common manifestations of pathophysiology in the gut is disrupted fluid transport which 
results in either diarrhea, when too much fluid is lost; or constipation when not enough fluid is secreted. 
The delicate balance of the ion and fluid status of the body is sustained by many signaling pathways 
integrating together to maintain and protect the body’s internal environment27.   
Cholinergic signaling is a widespread method of paracrine signaling, often involving cholinergic 
neurons (those that use the neurotransmitter acetylcholine) to convey action potentials or to stimulate a 
response in terminal tissues. The localization of nerves fibers in close proximity to the intestinal 
epithelium has been a known part of the system for decades, and their role in intestinal function has been 
under investigation just as long.  
Cholinergic stimulation of intestinal secretion was first confirmed in the rat jejunum, where not 
only a pro-secretory role for acetylcholine was described, but it was also determined that this function 
was likely mediated by muscarinic receptors—at the time more commonly known as post-junctional 
receptors28. Determining the secretory role of the intestinal crypt and that the villus/surface served as 
primarily an absorptive site was done by selectively damaging either the surface or the crypt of intestinal 
tissue before stimulation with acetylcholine29. The role of calcium in transport function of the intestine 
was first observed early on in rabbit ileum, where it was observed that serosal extracellular calcium is 
involved in intestinal electrolyte absorption and secretion, but mucosal calcium did not appear to be 
involved in basal or neuroendocrine-stimulated transport function30–32.  
The cellular processes behind cholinergic signaling in the intestinal epithelium were largely 
worked out in the T84 cell model, which is a human colon cancer model that exhibits endogenous 





The role of potassium ions in intestinal transport, and the proteins and mechanism involved, were 
defined first in the context of VIP-induced secretion, a cAMP-coupled mechanism of chloride secretion 
where the role of electroneutral NKCC1 and the Na/K-ATPase in chloride secretion of the intestine were 
confirmed34. In fact, T84 cells demonstrated a complex role of potassium ions in epithelial chloride 
secretion, with early studies that described the possibility of cAMP and calcium signaling activating two 
different types of basolateral potassium transport systems in addition to stimulating chloride transport35–37. 
The possibility that the common link between cAMP-induced secretion and calcium-induced secretion is 
the activation of two different basolateral potassium channels rather than the activation of different apical 
chloride channels was supported by differing sensitivities of VIP-induced chloride secretion and calcium 
ionophore A23187-induced secretion to inhibition by basolateral barium excess35,37.  
The general process determined for either cAMP- or calcium-induced chloride secretion includes 
net uptake of Na+, K+, and Cl- through the basolateral membrane via the bumetanide-sensitive NKCC1 
cotransporter, with Na+ and K+ being recycled at the basolateral membrane through Na+/K+-ATPase and 
the K+-channels, respectively. This allows for the accumulation of Cl- intracellularly above 
electrochemical equilibrium, generating part of the driving force for passive, net apical secretion of Cl-. 
The remainder of the driving force behind chloride secretion is a result of the inside the cell being 
electronegative.  
Not only is the potassium channel involved in chloride loading different in cAMP and calcium 
activated secretion, but the apical chloride channel may also be different based on the second messenger 
generated in response to the secretogogue36. In the case of acetylcholine, that would mean that the two 
points that that mediate chloride secretion consist of 1) a calcium activated potassium channel on the 
basolateral membrane and 2) a calcium activated chloride channel on the apical membrane.  
Acetylcholine and it’s analogue carbachol have been shown to act on the intestinal epithelium not 
through cyclic nucleotide signaling, but through increasing intracellular calcium38–42. Early on, T84 cells 
were determined to respond to carbachol in a pathway independent of cAMP as the carbachol response 





secretion35,36. It has also been demonstrated that increases in intracellular calcium alone are sufficient to 
induce an increase in Isc in the intestinal epithelium in an extracellular calcium-dependent manner without 
input from other signaling pathways by using reagents like thapsigargan—which increases cytosolic 
calcium but demonstrates effects on no other signaling pathways42.  
The pathway responsible for cholinergic-induced elevation of cytosolic calcium has been worked 
out extensively in many systems, defining the muscarinic receptors and the G-proteins they couple to in 
the context of many functions. In the intestinal epithelia and many other secretory tissues, acetylcholine is 
known to bind to muscarinic receptors and stimulate net secretion through the Gq/11 signaling pathway43,44. 
This signaling pathway involves the M3 muscarinic receptor in the human intestinal epithelium (in the 
mouse intestine the M1 receptor is also involved45) stimulating the Gq/11 pathway, activating PLC, 
increasing IP3, and depleting ER calcium to increase the cytosolic calcium concentration. The resulting 
increase in intracellular calcium causes apical calcium activated anion channels and basolateral calcium 
activated potassium channels to open, and results in a net efflux of chloride into the lumen followed 
passively by sodium and fluid through the paracellular pathway43. In addition to the characteristic chloride 
secretion, basolateral potassium secretion is important to maintain the electrical gradient required for 
chloride loading into the cell through the electrochemically coupled Na+/K+-ATPase/NKCC1/KCNN4 
transporters. Muscarinic regulation of basolateral potassium channels is therefore just as important as 
activation of the apical chloride channels in conducting cholinergic secretion.  
The cholinergic-induced secretory response is rapid and transient, a contrast to the often sustained 
response to cyclic nucleotide stimulation, that indicates a swift, internal mechanism for downregulating 
the calcium-induced response even in the presence of continued exposure to both stimulus and elevated 
intracellular calcium40.  The pathway involved in downregulating cholinergic-induced secretion was 
determined by a series of studies in T84 cells. The most obvious candidate to mediate the response was 
PKC, which was known to be activated in response to carbachol, but was determined to be unnecessary 
for chloride secretion as inhibition of the enzyme had no effect on epithelial chloride secretion46. Instead, 





inhibiting cholinergic chloride secretion via PI3K activation with no effect on the rise in intracellular 
calcium47. In addition to the unrelated effects of EGF signaling, carbachol itself was shown to cause 
transactivation of the EGF receptor via Gq signaling which resulted in activation of MAP kinase ERK. 
Specifically, inhibition of ERK led to the potentiation of the chloride secretory response to carbachol, and 
inhibition of the M3 receptor abolished the carbachol effects on ERK activation. This indicates a role for 
the enzyme in downregulation of cholinergic chloride secretion that is dependent on cholinergic 
activation48.  
The contributions from two different inhibitory pathways to downregulation of cholinergic 
secretion by EGF and carbachol are not particularly clear cut, as in addition to the major mode of action 
through PI3K activation and generation of lipid products, residual activation of PLC and generation of 
IP4 has been shown to occur in response to EGF signaling. Since carbachol demonstrated PLC/IP4 
mediated inactivation of secretion, whether PI3 kinase alone was sufficient to downregulate cholinergic 
secretion required investigation. Using insulin and IGF to activate PI3 kinase without generating IP4 
demonstrated that PI3K activation was sufficient to down-regulate cholinergic secretion, and that insulin 
and IGF are also able to downregulate cholinergic secretion49. A third distinct regulatory pathway was 
characterized involving EGFR activation, Src kinases, and p38 MAP kinase. Increases in intracellular 
calcium via carbachol or thapsigargan stimulated p38 phosphorylation in an EGFR and Src kinase 
dependent manner, and inhibition of p38 phosphorylation caused carbachol-induced secretion to be 
potentiated50. The many methods of negative regulation employed to keep cholinergic secretion in check 
highlights how important it is for the intestinal epithelium to keep tight control over fluid transport. 
Having many potential off-switches that are both self-regulated by muscarinic signaling and externally 
regulated by physiologically relevant signals like EGF, insulin, and IGF; offers a ‘fail-safe’ for the system 
to prevent dysregulation that could all too easily lead to potentially severe pathophysiology like diarrhea.  
As a well-defined signaling pathway that involves both the neuronal-specific nicotinic receptors 
and the epithelial-specific muscarinic receptors that has an easily quantifiable, functional readout in the 





validation for the enteroid cultures after differentiation, as monolayers, and in co-culture with the sub-
mucosal plexus. It was through validating our new enteroid culture systems that the observation was made 
that cholinergic signaling in the intestinal epithelia is not as simple as it is currently understood, as there 
is a significant nicotinic component in the epithelial response in the absence of a neuronal population that 
had previously been undefined. It was by characterizing this new nicotinic aspect, independent of 
muscarinic signaling, that the complexity of cholinergic signaling in the enteroids became apparent, 
revealing a variety of nicotinic receptor subunits in the epithelium and a secondary pathway upstream of 
intracellular calcium involved in mediating cholinergic anion secretion. Our contribution only scratches 
the surface of the previously undefined complexity of cholinergic signaling and leaves many questions 
still unanswered, but the culture systems defined in the process provides a means to systematically 



















III. Materials and Methods 
A. Mouse Enteroid Isolation and Culture 
Mouse enteroids were prepared from the jejunum of adult male (>1yo) Lifeact-EGFP transgenic 
mice51. The isolation and propagation of these mouse enteroid cultures was performed using a modified 
version of the method developed by Sato et al, as previously described9,52–55.  Briefly, mice were 
euthanized via isoflurane inhalation followed by cervical dislocation and a portion of the mid-jejunum 
~2cm long was removed and bathed in ice cold PBS with 200U/mL pen/strep at 4°C for 45 minutes. 
Isolated crypts obtained after EGTA chelation for 1 hour were embedded in Matrigel (Corning, 356231) 
in 24-well plates (Corning) and maintained in medium similar to that proposed by Sato et al9,11 consisting 
of a base medium (CMGF-; Advanced DMEM/F12 with 100U/mL penicillin/streptomycin, 10 mmol/L 
HEPES, and 1x GlutaMAX) with 50% WNT3A conditioned medium (produced by L-WNT3A cell line, 
ATCC CRL-2647), 15% R-SPONDIN1–conditioned medium (produced by HEK293T cell line stably 
expressing mouse R-SPONDIN1; generously provided by Dr. Calvin Kuo, Stanford University, Stanford, 
CA), 10% NOGGIN conditioned medium (produced by HEK293T cell line stably expressing mouse 
Noggin56), 1 × B27 supplement (Life Technologies), 1 mmol/L N-acetylcysteine (Sigma-Aldrich, St. 
Louis, MO), 50 ng/mL human epidermal growth factor (Life Technologies), and 100 μg/mL primocin 
(InvivoGen, San Diego, CA) (Table 1). Enteroids were cultured in a 5% CO2 atmosphere at 37°C and are 
passaged via mechanical trituration every 3-7 days.  
Enteroid cultures at passage 40 and passage 112 showed no significant difference 
morphologically or functionally, and so cultures from passage 40-155 were used. Enteroids used for the 
bulk of this study were generated from a single mouse, with preliminary cholinergic secretion 
experiments in enteroids isolated from 2 other male mice of different lineage and age at the time of 
isolation, but the same genetic background (C57BL/6) to verify the results across multiple individuals 





Mice used in these experiments were housed in the main animal facility at the Johns Hopkins 
School of Medicine. Full time veterinary care at Johns Hopkins University is provided by the division of 
Research Animal Resources and the Director of Laboratory Animal Medicine. The protocol was approved 
by the Hopkins Animal Care and Use Committee (protocol: M019M118).  
B. Monolayer Cultures 
Mouse enteroid monolayer cultures were produced by adapting methods previously described for 
human enteroid monolayers15,57. Briefly, Transwell inserts (polyester membrane with 0.4μm pore, 
Corning, 3470) were coated with 200µg/mL rat tail collagen I (Corning, 354236) and incubated at 37°C 
overnight. Filters were washed with base conditioned medium without growth factors (CMGF-) prior to 
plating. Mouse enteroids were freed from Matrigel and mechanically triturated before being plated in 
suspension above the filter and maintained in culture with 150μL medium in the apical well and 600μL in 
the bottom well, changed every other day. Monolayers were cultured in a 5% CO2 atmosphere at 37°C. 
Monolayer progression and confluence was estimated via trans-epithelial electrical resistance (TER; 
EVOM2 Voltohmmeter, World Precision Instruments).  
C. Mouse Enteroid Differentiation 
Enteroid cultures were expanded after passaging before the proliferation medium was replaced 
with various test formulations. The successful differentiation protocol was based on a protocol developed 
by Kozuka et. al. in a development project at Ardylex58. Mouse proliferation medium was switched to 
mouse differentiation medium; CMGF- with addition of 10% Noggin, 300ng/mL recombinant murine 
BMP4 (Peprotech 315-27-10μg), 2.5μM Thiazovivin (Sigma SML1045), 1 × B27 supplement, 1 mmol/L 
N-acetylcysteine, and 100 μg/mL primocin) for two days (Table 1). The enteroids that underwent 
differentiation were analyzed via qRT-PCR to confirm the loss of stem cell markers and an induction of 
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n-AC  FBS GlutaMAX GlutaMAX 
 B27 B27 Murine 
BMP4 
 Glutamine Antibiotic/Antimycotic Antibiotic/Antimycotic 
 n-AC 
 
n-AC Thiazovivin  Pen/Strep β-mecaptoethanol β-mecaptoethanol 
 hEGF 
 
hEGF Primocin  Blastocidin  bFGF 
 A83-01 
 
Primocin   Puromycin  EGF 
 Gastrin 
 
     GDNF 
 SB202190 
 
      
 Primocin       
 
Table 1: Media formulations used in cell culture  
Media compositions to maintain and differentiate various cell types in culture 
Abbreviations: Pen/Strep; Penicillin and Streptomycin, nAC; n-acetylcysteine, BMP4; bone morphogenic protein isoform 4, FBS; fetal bovine serum, BSA; bovine serum 





D.  Immunofluorescence and Confocal Imaging of Monolayers 
Monolayers were fixed in 4% paraformaldehyde (PFA; Electron Microscopy Sciences) for 30 
minutes and 3D cultures for 1 hour at room temperature in the dark. After being washed 3 times with PBS 
for 10 minutes, permeabilization was carried out using 0.1% Saponin in 2% BSA/15% FBS for 1 hour or 
0.1-0.5% TritonX-100 in 2% BSA/15% FBS for 20 minutes followed by blocking with 2% BSA/15% 
FBS for 40 minutes in a humidified chamber. Cells were washed with PBS and incubated overnight at 
4°C with the appropriate primary antibody (Table 2). Cells were washed with PBS 5 times for 10 minutes 
each and then incubated at room temperature in the presence of secondary antibody, labelled marker, 
and/or Hoechst (Table 2). After incubation, cells were washed with PBS 5 times for 10 minutes each in 
the dark and monolayers were cut out of the Transwell inserts and mounted in FluorSave Reagent 
(Calbiochem). 
Images of enteroid monolayers were obtained using an Olympus FV3000RS Confocal 
microscope (40x silicone immersion oil; 3.00x digital zoom; resonant scan with 16 frame average; 0.5μm 
Antibody Name Antibody/Label Source Dilution 
Na+/K+ ATPase 
(ATP1A1) 
Sodium/Potassium ATPase a5 (mouse monoclonal) DSHB 
59 
[1:100] 
SGLT1 Sodium-Glucose Cotransporter 1 07-1417 (rabbit polyclonal) Millipore 
60,61 
[1:100] 
DCLK1 Doublecortin Like Kinase 1 Ab37994 (rabbit polyclonal) Abcam [1:100] 
ChgnA Chromogranin A Ab15160 
(rabbit polyclonal) 
Abcam [1:100] 
ChAT Choline O-acyltransferase Ab70219 (rabbit polyclonal) Abcam [1:2000] 
VIP Vasoactive intestinal peptide Ab22736  (rabbit polyclonal) Abcam [1:2000] 
PGP9.5 Protein Gene Product 9.5 Ab108986  (rabbit 
monoclonal) 
Abcam [1:200] 
HuC/D Hu Antigen C/Hu Antigen D Ab184267 (rabbit 
monoclonal) 
Abcam [1:1000] 
WGA 488 Wheatgerm agglutinin W11261 Invitrogen [1:100] 
PHLN 633 Phalloidin A22284 Life 
Technologies 
[1:100] 
Hoechst 405 Hoechst 405 33342 Sigma [1:2000] 
Table 2: Antibodies and labels used for immunofluorescence  
Primary antibodies and labels used for staining of cell culture and tissue. Short-hand used, target or label name, reference 





step size; NA= 1.25). Analysis was carried out using the Fluoview analysis and reconstruction software 
(FV31S-SW, v2.1.1.98).  
E. Ussing Chamber/Voltage Clamp Technique using Current Clamp Short-Circuit 
Current Measurements 
The protocol used to quantitate anion secretion data was previously published in detail62. In 
summary, Transwell inserts with confluent enteroid monolayers were mounted in Ussing chambers and 
electrogenic ion transport determined using a voltage clamp (VCC MC6 Multichannel Voltage/current  
Clamp using P2302T sliders; Physiologic Instruments). The apical and basolateral chambers (P2300 
Ussing chamber in a EM-CSYS-6 system) were filled with bathing solution that was gassed continuously 
with 95% O2/5% CO2, maintained at 37°C, and connected to the voltage-current clamp via Ag/AgCl 
electrodes and 3 mol/L KCl agar bridges. Bathing solution consisted of 120mM NaCl, 25mM NaHCO3, 
3.3mM KH2PO4, 0.8mM K2HPO4, 1.2mM CaCl2, and 1.2mM MgCl2, gassed with 5% CO2, at pH 7.4. In 
addition, bathing solution in the basolateral chamber was supplemented with 4mM glucose as an energy 
Compound Abbreviation Manufacturer Final Concentration Application 
Forskolin Fsk Sigma 5µM Basolateral 
Carbamoylcholine Chloride CCh Sigma 10µM63,64 Basolateral 
Hexamethonium Bromide Hex Sigma 10µM Basolateral 
Atropine Atro Sigma 1µM Basolateral 
Bethanechol Chloride BCh Calbiochem 10-300µM Basolateral 
(-)-Nicotine hydrogen 
tartrate salt  




BPO27 MedChem Express 25μM Apical+Basolateral 
Calcium-activated Chloride 
Channel inhibitor A01  
(CaCCinh-A01) 
A01  10μM Apical+Basolateral 
BAPTA-AM BAPTA-AM Invitrogen 25μM Apical+Basolateral 




EGTA Sigma 1.4mM Apical or Basolateral 
 
  
Table 3: Compounds for transport and calcium experiments 
Table summarizing the reagents used in transport analysis or intracellular calcium measurements using the mouse 






substrate; while the apical chamber was supplemented with 4mM mannitol to maintain osmotic balance. 
Reagents are listed in Table 3. Current clamping was used and short-circuit current (Isc) and TER were 
recorded by the Acquire and Analyze software (ver. 2.2.2, Physiologic Instruments 2005). Data were 
normalized to the surface area of the monolayer (0.33cm2) in Microsoft Excel before being analyzed and 
graphed in GraphPad Prism8/9.  
F. Quantitative Real-Time Polymerase Chain Reaction 
Expression of mRNA was determined according to the protocol previously published62. Total 
RNA was extracted from three different passages of mouse jejunal enteroids plated as monolayers using 
the PureLinkRNA Mini Kit (Life Technologies) according to the manufacturer’s protocol. 
Complementary DNA (cDNA) was synthesized from 1μg of mRNA using SuperScript VILO MasterMix 
(Life Technologies). Quantitative real-time polymerase chain reaction (qRT-PCR) was done using Power 
SYBER Green Master Mix (Life Technologies) and a QuantStudio 12k Flex real-time PCR system 
(Applied Biosystems). Samples were run in triplicate using 5ng of cDNA for each reaction. Gene specific 
primer sequences are listed in Table 4. Ribosomal RNA 18S (Rn18s) was used as the internal control for 
normalization. 
qRT-PCR was performed on monolayers grown under both non-differentiated and differentiation 
conditions to verify cell identity in the monolayer. Expression of the various muscarinic receptors and 
nicotinic receptor subunits was determined under both non-differentiated and differentiated conditions. 
Gene Abbv. Fwd Rev Product 
(bp) 






Lgr5 CGAGCCTTACAGAGCCTGATACC TTGCCGTCGTCTTTATTCCATTGG 143 
Na+-K+-2 Cl- 
Channel 
Nkcc1 TGCGAGAAGGTGCACAATAC TGTTTGGCTTCATACGACCA 60 
Sucrase 
Isomaltase 
Si GCTATCGCTCTTGTTGTGGTT TTCCAGGACTAGGGGTTGAAG 85 
Villin Vil1 TCAAAGGCTCTCTCAACATCAC AGCAGTCACCATCGAAGAAGC 114 
Mucin 2 Muc2 TGCCCAGAGAGTTTGGAGAG   CCTCACATGTGGTCTGGTTG   123 
Double 
Corticotropin-
like Kinase 1 
Dclk1 TCCACCGGAATTGAACTCGG GGGAGCGAACAGTCTCAGA 65 














Cftr CCCTTCGGCGATGCTTTTTC AAGCCTATGCCAAGGTAAATGG 166 



































































Chrna10 ATGGATGAACGGAACCAAGTG GTCCCAATGTAGGTAGGCGT 78 
Cholinergic 
Receptor 
Nicotinic Beta 1 
Subunit 
Chrnb1 TGAAGAAATGAGCACAAAGGTG TCCCAGCTTAACCTGTAGTCG 63 
Cholinergic 
Receptor 
Nicotinic Beta 2 
Subunit 







Nicotinic Beta 3 
Subunit 
Chrnb3 TGCTGACGGACGTTTTGAGG GAGGAGTCCAACTGACGGT 77 
Cholinergic 
Receptor 























Chrng CTCCCTGAATGAACGAGAGGA GGCCTTCGTAGTCTTTTGGGT 101 
Primers used to identify Adenylyl Cyclase Expression 
Adenylyl Cyclase 
1 
Adcy1 TTGGCAAGTTCGATGAGTTAGC GGCGTGATCCGTCTTAGGC 110 
Adenylyl Cyclase 
3 
Adcy3 ATGTCACCGTGGCAAACAAGA GCAATGATGAGGTAGGTTTCGAT  
Adenylyl Cyclase 
6 
Adcy6 TGAGTCTTCTAGCCAGCTCTG CAGCACCAAGTAGGTGAACCC 92 
Adenylyl Cyclase 
8 
Adcy8 CGGAGGTAGTGATGAACGTGT CCTTGAGAGGGTCCATTGGAG 96 
Primers used to identify Anoctamin Expression 
Anoctamin1 
(Tmem16A) 
Ano1 AGGAATATGAGGGCAACCTG CGACACCATGGATTTTGGTA 75 
Anoctamin6 
(Tmem16F) 
Ano6 GTATGAGGCCCAGTGCAATC TTCCCACAGGTGGTAAATGG 81 
Primer used to identify expression of control genes  
18s Ribosomal 
RNA 
Rn18a GCAATTATTCCCCATGAACG GGGACTTAATCAACGCAAGC 68 
Table 4: Gene Specific Primer Sequences  
Sequence and expected product length of the amplification product for the primers used for qRT-PCR. qRT-PCR, real time quantitative 
reverse transcription polymerase chain reaction 
 
G. Mouse Enteroid Transduction 
 A selection of the plasmid-bearing Mission shRNA bacterial stock E. coli was purchased from 
Sigma, individual clones were picked and expanded in LB broth + Ampicilin [100μg/mL] on a shaker 
overnight at 200rpm and 37°C. Plasmids were isolated by MINIPrep according to the manufacturer’s 
directions (QIAprep Spin Miniprep kit; 27106) and DNA was quantified. HEK293 cells  
were cultured in Dulbecco's modified Eagle medium/nutrient mixture F-12 supplemented with 10% fetal 
bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin in a 5% CO2/95% air atmosphere at  
37°C. Two days after splitting, HEK cells were transfected with isolated plasmid [1μg] using  
Lipofectamine 2000 according to the manufacturer’s protocol (Invitrogen, 11668-019). After overnight 





sodium butyrate [5mM] for at least eight hours. Medium was refreshed and the cells maintained for two 
days. Supernatant was then collected and filtered via syringe using a 0.20μm filter (Corning, 431229) and 
stored at -80°C until use.  
Transduction of the mouse enteroids was performed by melting the Matrigel in Cell Recovery 
Solution at 4°C for 45 minutes mechanically triturating the enteroids 10-15 times with a multichannel 
pipettor, and diluting in CMGF- before spinning down at 1200rpm for 10 minutes at 4°C. Enteroid pellets 
were combined and re-divided into sterile Eppendorf tubes in 250μL mouse minimal medium with CHIR-
99021 [10μM], Y-27632 [10μM], polybrene [8μg/mL], and individual lentivirus-containing supernatants 
(Table 5) (250μL) and transferred to a 24-well plate. Suspended enteroids were placed in a spinoculator 
(600g, VWR) at 32°C for 1 hour and then transferred to an incubator with 5% CO2/95% air atmosphere at 
37°C for a further 4 hours. Enteroids were spun down and washed gently in CMGF- three times before 
Gene Abbv TRCN# Source Product Type Clone ID 
Adenylyl Cyclase 6 
(mouse) 












Adenylyl Cyclase 8 
(mouse) 




















Table 5: Lentiviral shRNA Sequences for knockdown in mouse enteroids  
Identity, TRCN#, and clone ID numbers for bacterial glycerol stocks from the Sigma MISSION shRNA library targeting the 
mouse sequences of the indicated target for knock-down 
 
Gene Plasmid Source ID# Function 




Addgene 114189 Cholinergic M3 
receptor 
Table 6: Lentiviral shRNA Sequences for Caco-2 cell overexpression  






being plated in Matrigel with minimal medium supplemented with CHIR-99021 [10μM] and Y-27632 
[10μM] for 24 hours. Medium was then replaced without the addition of the Y- and CHIR-compounds.  
After the first few post-transduction passages, Puromycin [1.25μg/mL] was added to the minimal 
medium and maintained for selection. Enteroids were passaged as needed. Expression analysis for the 
various knock-down variants was performed via qRT-PCR compared to control enteroids. 
H. Caco-2/BBE cell culture 
Caco-2 cells (C2BBe1) were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
supplemented with 25 mmol/L NaHCO3, 0.1 mmol/L nonessential amino acids, 10% fetal bovine serum, 
4 mmol/L glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin in a 5% CO2/95% air atmosphere 
at 37°C. Plasmid pGP-CMV-GCaMP6s (Addgene plasmid; no. 40753; http://addgene.org/40753) was 
cloned into lentiviral vector pCDH-EF1-MCS-IRES (puro) and lentiviral particles produced (Table 6). 
Caco-2 wild-type were transduced with GCaMP6s lentiviral particles and puromycin selected (10 
mg/mL). Caco-2 cells stably expressing GCaMP6s were transduced with lentiviral particles produced 
from lentiviral vector pLV-EF1aa IRES-3HA-CHRM3 (Blasticidin) (M3-PAmCherry1, Addgene 
plasmid; no. 114189, cloned into lentiviral vector pLV-EFa-IRES) under standard protocol. Caco-2 cells 
stably expressing GCaMP6s and 3HA-CHRM3 were maintained under puromycin and blasticidin 
containing Caco-2 media.  For calcium imaging, experiments Caco-2 cells were seeded into 12-well 
Transwell plates (1.2 X 105 cells/ well). Cells were grown for 12–15 days post-confluence and were 
serum deprived for 2–3 hours before study. 
I. Calcium Measurements 
Live images of GCaMP fluorescence for calcium measurements using the Caco-
2/M3R/GcAMP6s monolayers were obtained with an Olympus FV3000RS confocal microscope (10x 
objective lens; 2.00x digital zoom; resonant scan with 16 frame average; 0.3μm step size; pinhole: 2.13 
Airy units, NA= 0.40) at 37°C within a sealed environmental chamber (OkoLab stage top plus transparent 





images were taken approximately once every second for ten minutes. Average fluorescence for the entire 
frame at each time point was generated in MetaMorph Basic (v7.7.3.0) and transferred to Microsoft Excel 
for normalization before being transferred again to Prism8/9 for graphing and analysis. 
J. Submucosal Plexus Isolation and Culture 
 SMP Isolation was carried out using a slightly modified protocol65,66. Wnt1-cre:tdTomato mice 
(>3 weeks of age, female) were anesthetized with isoflurane and killed by cervical dislocation. A 
laparotomy was performed and the small intestine was removed and lavaged with PBS containing 3x 
Antibiotic-Antimycotic (Anti-Anti; Invitrogen), then cut into 2-cm-long segments and placed over a 
sterile plastic rod. The LM-MP was mechanically peeled off from the underlying tissue using a sterile 
cotton swab and discarded. The underlying tissue that remained, consisting of the epithelia and sub-
mucosal layers, was slit open and transferred to Opti-MEM medium (Invitrogen) containing 2x 
antibiotic/antimycotic (Invitrogen) on ice.  
The epithelial cells were removed through sequential washes in Citrate Buffer (50mM trisodium 
citrate, 95mM sodium chloride, 8mM potassium phosphate, 5.6mM sodium phosphate dibasic, 1.5mM 
potassium chloride). The first two washes (1x Citrate Buffer +1X antibiotic/antimycotic, +5% FBS) for 
30 minutes at room temperature while shaken vigorously and the third (1x Citrate Buffer +1X 
antibiotic/antimycotic) agitated at 37°C for 30 minutes. Fragments were then transferred to digestion 
buffer. 
The SMP was dissociated in a digestion buffer consisting of M199 medium (Invitrogen) 
containing 0.1% BSA, 1mM CaCl2, 20mM HEPES, 150μM P188, 50U/mL DNase I (Worthington, 
LS0041746), 300U/mL collagenase type 2 (Worthington), and 5% D-+-Trehalose Dihydrate (MP 
Biomedical) rotated for 20-30 minutes at 37°C; until just before all the fragments are completely 
dissolved. The dissociated cells were washed in PBS then passed through a 70-μm and subsequently 





Cells were cultured for 1-2 days in stem cell medium (SCM +GFs) consisting of Neurobasal 
medium containing 1× B27, 0.7% BSA, 2 mM GlutaMAX, and 100 U/mL antibiotic/antimycotic, 0.1% 2-
mercaptoethanol, plus 20 ng/mL recombinant human fibroblast growth factor (bFGF), 20 ng/mL 
recombinant human epidermal growth factor (EGF), and 20 ng/mL recombinant human glial cell-derived 
neurotrophic factor (GDNF) (Invitrogen) (Table 1). 
Sorting the SMP neurons and glia from non-neuronal contamination was performed by negative 
cell sorting. Cultures were dissociated with Accutase (Millipore-Sigma) and DNAse I (20μL/mL) for 20 
minutes at 37°C and then passed through a 40-μm nylon mesh cell strainer to yield single cells. Cells 
were washed with PBS and incubated with PE anti-mouse CD45 (clone 30F11; Biolegend 103105) for 20 
minutes at 37°C then washed with PBS before incubation with Anti-PE microbeads (Miltenyi). Labelled 
cells were passed through at least 3 magnetic LS columns (Miltenyi) in succession. The CD45- fraction 
was cultured in SCM +GFs for 5 days.  
CD45- cell cultures were plated on either glass coverslips (coated with 1:1 diluted Matrigel) or 
the bottom side of Transwell filters dual-coated with 1mg/mL rat tail collagen 1 (Corning, 354236) then 
20μg/mL fibronectin (Santa Cruz; sc-29011) (apical coating: 200μg/mL rat tail collagen I) and allowed to 
adhere for 30-60 minutes at 37°C before being gently flipped into warm SCM –GFs and the cells were 
incubated at 37°C in 5% CO2. Medium was gently refreshed every two days using a 1mL pipettor.  
K. SMP Culture Imaging: ChAT and VIP distribution 
SMP cultures from five littermate mice combined and plated on slides coated with 1:1 diluted 
Matrigel on Millicell EZ slides (4-well glass; PEZGS0416) in triplicate and pre-differentiated in SCM 
for 6 days before being switched to one of five experimental medias. After 3 days in the experimental 
media, cultures were gently washed with PBS and then fixed in 1% PFA for 5 minutes in the dark at 
room temperature. Slides were then rinsed gently with PBS and stored in PBS in the dark at 4°C until 
stained.  
Slides were permeabilized with 0.3% TX-100 / 10%BSA / 15%FBS for 30 minutes before 





minutes. Slides were then incubated with either ChAT or VIP primary antibodies (Table 2) in 
blocking solution in a humidified chamber overnight at 4°C. The next day, slides were gently rinsed 
with PBS before being washed 3 times in the dark at room temperature for 10 minutes. Secondary 
antibodies and labels (Table 2) were incubated at room temperature in the dark in 10% BSA block for 
45 minutes. Slides were gently rinsed, then washed 3 times with PBS (10 minutes each in the dark at 
RT) and mounted with FluoroSave before being sealed. 
SMP culture images were captured using an LSM-510 META laser scanning confocal 
microscope (Zeiss; 20x objective lens; 1.00x digital zoom; 4 frame average) running ZEN 2012 (black 
edition) imaging software. Every Hoescht+ cell was imaged for each condition and cells were counted 
manually using the Hoechst nuclear stain to determine total cells. Data were recorded in Microsoft 
excel and transferred to Prism8 for graphing. 
L. Co-plating the SMP and enteroids in a 3-dimensional system 
 After SMP culture in neural differentiation condition (SCM –GFs) for 5-7 days on glass 
coverslips or 24-well plates, enteroids were dissociated according to standard passaging protocol and 
plated in 1:1 diluted Matrigel on top of the SMP cultures and allowed to polymerize for 10-15 minutes 
before the co-cultures were fed with Sato1,2 enteroid-supporting medium (Table 1). Media was changed 
every two days. 
M. Forskolin-induced Swelling Assay 
The FIS assay is modified from that previously described12,13,20,67,68. In short, 3D organoids have a 
closed, ‘inside-in’ morphology. Luminal secretion thus increases the volume of the enteroid. This change 
in volume can be observed post-stimulation (5μM Fsk) and was imaged post-incubation with Calcein 
Green AM (2μM, Invitrogen) using a Keyence All-in-one Fluorescence Microscope B7-X700 series with 
an incubation system to support live-cell imaging to obtain images every 3 to 5 minutes for 30 minutes. 
The cross-sectional area of each spherical enteroid over the time-course was then measured in ImageJ 





Rotterdam) and normalized in Microsoft Excel to the initial cross-sectional area to generate a percent 
increase in size over time before being transferred to Prism8 for graphing and analysis.  
To account for the possibility of a suppressive SMP effect on FIS in the enteroids, no minimal or 
maximal volume change cutoffs were applied when analyzing the co-culture data and associated controls. 
Enteroids were excluded from the analysis if in any image frame they: 1) were below size threshold, 2) 
touched the edge of the frame, 3) disappeared for more than one frame, 4) experienced a sudden, sharp 
(dependent on initial size, ex: >2% drop in enteroids under 1000 pixels2) drop in cross-sectional area 
between two adjacent time points (‘popped’), 5) when cross checked with the base image were not 
confirmed enteroids, or 6) when cross checked with the base image were actually 2 or more enteroids at 
least partially overlapping, but not fusing (enteroids in multiple z-planes overlapping, fused enteroids 
were included as long as their original cross-sectional areas were summed as well). 
N. Co-plating the SMP and enteroids in a 2-dimensional system 
 After culture in neural differentiation condition (SCM –GFs) for 5-7 days on the inverse side of 
dual-coated Transwell filters (0.4 μM pore, Corning, 3470 or 1μM pore; Millicell, MCRP24H48), 
Transwells were transferred to a new plate with warm enteroid medium (minimal media + various 
supplements) and enteroids were dissociated and plated in warm enteroid media in the apical well. 
Enteroid monolayer confluence was measured daily using an EVOM2 Voltohmmeter. Media was gently 
refreshed every two days. 
O. Immunofluorescence of 2D Co-cultures 
Images of co-cultures on 1.0μM pore Transwell filters were obtained using an Olympus 
FV3000RS Confocal microscope (40x silicone immersion oil; 3.00x digital zoom; resonant scan with 
16 frame average; 0.5μm step size; NA= 1.25). 3D reconstruction of the 2D co-culture was carried out 
using the CellSens module of Fluoview (FV31S, v2.1.1.98) to perform deconvolution on the images and 





P. Tissue Fixation and Processing to determine mouse SMP ChAT distribution  
Small intestinal tissue from three female, littermate ChAT-cre:tdTomato mice wash flushed with 
PBS +3X antibiotic/antimycotic to remove luminal contents. The tissue was segmented into the 
duodenum, jejunum, and ileum, the longitudinal muscle/myenteric plexus (LMMP) was mechanically 
peeled away and the remaining tissue was slit open along the mesenteric border and then fixed in PFA for 
3 hours at 4°C before being stored at 4°C in PBS.  
When preparing for staining, the mucosa was removed using a pair of clean glass slides, one slide 
anchored one end of the tissue submerged in enough PBS to cover the tissue and keep hydrated in a 
10cm2 dish while the other gently scraped off the mucosa. The tissue segments were further divided for 
staining with multiple antibodies. Tissue pieces were then washed with PBS and permeabilized for thirty 
minutes in 0.3% TritonX-100/10%BSA/15%FBS at room temperature in the dark before being changed 
to block without TritonX-100 for a further thirty-minute incubation. Primary antibodies (Table 2) were 
incubated over two nights at 15°C with shaking at 60rpm in 10% BSA block. The tissue was washed 
thoroughly with PBS before being incubated with secondary antibody (Table 2) in PBS at 15°C, 60rpm 
overnight. Tissues were washed thoroughly in PBS and mounted flat on a slide with Fluorsave mounting 
media and sealed. 
Small intestinal tissue imaging was performed using a Leica SP8 confocal microscope (HC PL 
APO 20x objective lens; 2.25 digital zoom; 4 line average; 0.5μm step size, NA=0.75) and LAS X 
(Leica Application Suite X, ver. 3.5.5.19976) software. Depending on the segment, between 20 and 65 
random fields with at least one HuC/D-positive (also known as ELAVL3 and ELAVL4 or Hu antigen C 
and D) cell body. Total cell bodies expressing HuC/D with or without ChAT were counted per 
segment. Distribution was not averaged to better display the variability between intestinal segments 






Q. Cryo Tissue Preparation and Processing: Identification of ChAT+ epithelial cells 
Small intestinal tissue segments from ChAT-cre:tdTomato mice were flushed with PBS +3X 
antibiotic/antimycotic to remove luminal contents and the myenteric layers were mechanically peeled off. 
Tissue was submerged completely in 4% PFA at 4°C for 2 hours and then transferred to 30% sucrose and 
incubated at 4°C overnight. Tissue was then submerged in OCT (Optimal Cutting Temperature, 4583, 
Tissue-Tek) and frozen in liquid nitrogen. Blocks were stored at -80°C before being sectioned by the 
Hopkins Mouse Physiology Core. 
To prepare for imaging, frozen slides were brought to room temperature in the dark (10 minutes). 
A short secondary fix (2% PFA for 10 minutes) was followed by 3 washes in PBS-Tween (10 minutes 
each). Tissues was then permeabilized with 0.3% TritonX-100 / 10% BSA for 20 minutes and then 
blocked with 10% BSA for a further 30 minutes. Primary antibodies against ChAT, DCLK1, and ChgnA 
were incubated overnight at 4°C in a humidified chamber in 2% BSA (Table 2).  
The next day, slides were washed 7 times in PBS while rocking (dark, 10 minutes each) before 
the secondary antibodies were incubated for 1 hour in the dark at room temperature in a humidified 
chamber. Slides were then washed 5 times in PBS for 10 minutes each in the dark while rocking before 
coverslips were mounted using FluorSave mounting media. Slides were stored at 4°C until imaged. 
Images of cryo-preserved jejunal slices were obtained using an Olympus FV3000RS Confocal 
microscope (40x silicone immersion oil; 4.00x digital zoom; galvano scan with 5 frame average; NA= 
1.25; 2048x2048). Fluoview (FV31S, v2.1.1.98) imaging software was used to analyze and add scale 
bars. 
R. Confocal 
Confocal imaging was carried out at the Fluorescence Imaging Core of the Hopkins Basic 
Research Digestive Disease Development Center. This work was supported by the NIH NIDDK Center 





S. Statistical Analysis 
qRT-PCR data was acquired using the QuantStudio program and analysis—normalizing to mouse 
Rn18s expression (ΔCt)—was performed in Microsoft Excel and graphed in Prism8. Expression 
differences between differentiated and non-differentiated monolayers was determined by the fold-change 
(2-ΔΔCt) between ΔCt for each gene of interest with the non-differentiated cultures set to 1.00. Significance 
was determined via unpaired two-tailed Student’s t-tests comparing expression in differentiated 
monolayers to expression in the non-differentiated monolayers (GraphPad Prism version 8.3.0). 
Analysis of current clamp data were performed in Excel by normalizing the Isc to the surface area 
of the monolayer and subtracting the average Isc of the baseline current immediately prior to addition of 
the reagents, which was then compared to the peak Isc. Significance for most experiments was determined 
via Student’s unpaired t-tests to compare experimental conditions to the control responses, but as the 
experiments characterizing the differentiated monolayers were done without internal duplicates for each 
condition during each experiment the Student’s paired t-test was used to determine significance for those 
experiments. Finally, One-way ANOVA with Tukey correction was used to determine significance for 
dose response curves as each condition was compared to every other condition rather than to a single 
control condition. The statistical analysis method used is indicated in each figure legend (GraphPad Prism 
version 8.3.0). Final graphs were generated using Prism8/9 with data from the individual traces included. 
Results are reported as mean ± SEM as either μA/cm2 or percent of control response.  
Kinetics for bethanechol and nicotine were determined in Microsoft Excel using the Lineweaver-
Burk method. Each experiment counted as n=1 regardless of the number of monolayers studied. 
Area under the curve (AUC) analysis of transport data were performed using the AUC function 
for XY analysis in Prism 8/9. Due to the rapid cholinergic response, peaks of a single point were included 
in the analysis. 
The ‘Time to Resolution’ of various transport curves was determined by taking either the time at 
which Isc returned below baseline (0μA/cm2) or the end of the experiment, whichever came first after 





length of time after maximum Isc when the current returns to baseline. Data were then transferred to Prism 
8/9 for graphing and statistical analysis. 
Real-time live cell calcium analysis was performed using the Olympus FV3000RS confocal 
microscope to generate t-stacks at a rate of 1 second / image. These stacks were exported to Metamorph 
where a fluorescence intensity graph was generated for the average fluorescence of the entire frame for 
each time point and the numerical data were exported to Excel where it was normalized to the first 100 
seconds (F0, baseline) or for the EGTA data the first 40s were averaged as the baseline. Normalized data 
were transferred to Prism8/9 to generate final graphs and calculate significance of both peak fluorescence 





IV. Mouse Jejunal Enteroid Monolayer and Differentiation 
Development and Characterization 
A. Background 
Intestinal enteroids are a powerful model. The ability to isolate and propagate the primary stem 
cell population ex vivo indefinitely without introducing cancerous mutations that may alter other functions 
is a massive step forward for intestinal physiologic studies. The fact that these populations retain not only 
their organismal identity as conferred by their genetic and epigenetic sequences, but also their organ and 
local identities in that enteroids isolated from the duodenum retain their duodenal gene expression 
patterns in culture which are distinct from those of other intestinal segments like the stomach or colon. 
However, as incredible an advance as the system is, there is always room for improvement. In this case, 
the isolated crypts and intestinal enteroids are propagated and assayed as 3-dimensional spheroids or 
lobed structures that are embedded in a Matrigel matrix. This severely limits the types of assays that can 
be performed, introduces high levels of background—whether in the form of fluorescence by the Matrigel 
when imaging or excess extracellular matrix when protein is isolated—to the loss of numbers when trying 
to recover specimens for analysis, to the lack of easy access to both sides of the polarized epithelial layer, 
and finally issues of uneven distribution of reagents and dyes. The removal of the enteroids from the 
surrounding matrix to allow for a 2-dimensional monolayer to develop can solve many of these problems. 
Access to both the apical and basolateral surfaces is one of the biggest physiological weaknesses of the 
3D system that is resolved by the monolayer culture in addition to the technical benefits. A successful 
monolayer protocol for human enteroids and colonoids was developed several years ago and has been 
utilized to great effect22, however, when applied to the mouse enteroids, the cultures never reach 
confluence. The first aspect of this project was to determine the requisite conditions for successful culture 






The intestinal epithelium is comprised of several major classes of epithelial cells that can further 
be divided based on specific markers or signaling molecules. Traditionally used cancerous cell lines do 
not represent the full scale of cell variety that the intestinal epithelium supports in normal physiology.  
The intestinal epithelium is divided into two functional lineages during differentiation.  Notch 
signaling and the downstream transcription factor ATOH1 has been shown to be the main determinant of 
cell fate in the intestinal epithelium, determining if differentiated cells become secretory (goblet69, 
enteroendocrine70–72, and paneth73,74 cells) or absorptive (enterocytes75)76,77. Interestingly, a rare cell type 
called tuft cells, recently determined to function in immune responses to type II parasite infections, do not 
appear to fit into this cell fate model78–81. 
Each cell type of the intestinal epithelium carries out a distinct function, and loss or disruption of 
these functions often causes pathology. Understanding the physiology and pathophysiology of the 
intestinal epithelium requires all aspects of the epithelia to be present. When a population is missing or 
over-represented, physiology due to the communication between cell populations is missing or altered, 
potentially blocking key aspects of the physiological response. 
The early differentiation conditions for human enteroids consisted of the removal of WNT3A and 
the p38 MAPK inhibitor SB202190 from the medium for 5 days. Later RSPONDIN1 was also removed to 
generate the conditions currently used for differentiating human enteroids in culture. It has also been 
shown that differentiation of human enteroids in the presence of Notch inhibitor DBZ is sufficient to alter 
the cell fate ratio, significantly increasing the number of secretory cells in culture, a technique used to 
study physiology and pathophysiology of some of the rarer cell types82. 
The human enteroid differentiation process has since been thoroughly tested, inducing changes 
similar to those observed along the small intestinal crypt-villus or colonic crypt-surface axis, including an 
increase in monolayer TER and cell height, an increase in various differentiation and specific cell type 
markers, and a decrease in proliferative and stem cell markers15,24,57,58,62. However, differentiation of the 





derived cultures died by day four. Cutting the differentiation short to 2 or 3 days did not exhibit any 
marked reduction in proliferative markers that isn’t accounted for by the increased cell death.  
The three pathways most involved in intestinal differentiation are the Wnt, Notch, and Bone 
Morphogenetic Protein (BMP) pathways. Differentiation conditions including the Wnt antagonist 
dipkoff1, notch inhibitor DAPT, and removal of NOGGIN from the media (an endogenous BMP4 
inhibitor), were tested to see if the cultures could be pushed into differentiating. Previous experiments in 
our lab testing the effects of these inhibitors alone in culture demonstrated a partial effect at best by qRT-
PCR. 
 While our efforts did not succeed, in 2017 a group at Ardelyx published successful protocols for 
the generation of monolayers and differentiation of mouse and human small intestine and colon 
enteroids58. Mouse jejunal monolayers were differentiated and demonstrated increased numbers of Muc2+ 
goblet cells, ChgnA+ enteroendocrine cells, ANPEP+ absorptive cells, and Lysozyme+ Paneth cells via 
confocal microscopy and mRNA sequencing. Sequencing data further demonstrated an increase in 
sucrase-isomaltase, lactase, and NHE3 in addition to decreasing Ki67 (proliferation marker) and LGR5 
(intestinal stem cell marker) expression. Ion transport analysis showed net Na+ absorption and apical 
acidification in differentiated cultures. However, the TER of differentiated jejunum was not tested, nor 
were several other common markers of specific cell types included in the analysis of the cultures. 
Additionally, age matched, non-differentiated cultures were not present in their analysis, so it is 
inconclusive if their results are due to their differentiation media composition or to their proposed 
monolayer conditions. We proposed to more thoroughly characterize the differentiation protocol by 
analyzing mRNA expression of an expanded panel of intestinal proliferation and differentiation markers, 
recorded TER over time, and compared stimulated anion secretion in monolayers differentiated according 






1. A minimal media composition pushed mouse enteroids to a more proliferative state. 
The minimal media condition developed to support mouse enteroid monolayers83 appears to have 
the effect of driving the 3D mouse cultures to a more proliferative state, reducing the number of lobed 
enteroids in culture and increasing the average enteroid size in pair-matched wells (Table 1, Figure 1, 
data not shown). Comparatively, crypts isolated into the mouse minimal condition grew larger enteroids 
than the same isolation plated in the Sato condition, though the numbers of enteroids established were 
about equal in both wells (data not shown). 
Using the mouse minimal media as a base, tests of differentiation conditions for mouse enteroids 
that were being published at the time led to cell death. Once the mouse monolayer platform was 
available, TER measurements were used as a real-time measure of differentiation to test several 
conditions which continued to result only in enteroid loss. The TER of differentiated intestinal 
monolayers of various cell types is increased compared to undifferentiated intestinal cultures, when our 
tested conditions did not increase the TER as expected but rather caused it to plummet within days 
indicating loss of the culture, the conditions were deemed a failure and further testing not conducted.  
Figure 1: Mouse jejunal enteroids plated in proliferative conditions 
A) Enteroids passaged in Sato media (3 days post-passage) are smaller and of a mixed-lobed morphology compared to paired 
enteroids passaged into B) minimal media for 3 days. Enteroids in both conditions were previously passaged together in Sato 
media for 32 passages before being divided into either Sato or minimal medium and imaged three days later. Enteroids grown 
in minimal media have a predominantly spherical morphology compared to the mixed spherical and lobed morphologies 





2. Development of mouse jejunal monolayers and monolayer differentiation83 
Using mouse enteroid lines isolated from the jejunum and the minimal media composition that 
produced enteroids that were predominantly non-differentiated (ND53), a protocol to generate confluent 
monolayers on Transwell filters was developed83. This protocol required making several key changes to 
the mouse enteroid and human monolayer systems: 1) Coating Transwell filters with a high concentration 
(200μg/mL) of rat tail collagen I instead of 34μg/mL of human placental collagen IV; 2) Removing the 
TGFβ1 receptor inhibitor A83-01 from the media, which prevented monolayer formation in mouse 
enteroids when present; and 3) Using non-enzymatic methods to passage the cultures, enzymatic digestion 
with TrypLE, Accutase, and Trypsin all prevented the formation of confluent monolayers even after 
several passages using mechanical disruption of the enteroids. The last two steps were necessary because 
A83-01 prevented the monolayers from becoming confluent, while using enzymatic dissociation to 
passage the mouse enteroids even once prevented monolayer formation for multiple passages. 
Once the monolayers were confluent as determined via a TER over 100 Ω٠cm2, the monolayers 
were switched to a promising differentiation media published by the company Ardelyx which included 
the withdrawal of WNT3A/RSPONDIN-1 and the addition of BMP4 (300ng/mL) and Thiazovivin 
(2.5μM)58. These cultures exhibited a rapid and significant increase in TER over two days when 
compared to cultures maintained in ND media (Figure 2A) and all experiments were performed on 
cultures 2 days after switching to the differentiation media as suggested58.  
Confocal imaging was used to verify that the monolayers were 1) confluent as determined by a 
single layer of nuclei staining and 2) had apical-basolateral polarity based on confocal imaging with 
basolateral marker Na+/K+-ATPase and an apical marker WGA (used for non-differentiated cultures) or 
SGLT1 (used for differentiated cultures) (Figure 2B, C). The presence of intestinal cell types, including 
stem cells (Lgr5), enterocytes (Si), goblet cells (Muc2), and tuft cells (Dclk1) was determined by qRT-
PCR (Figure 2D, E). The non-differentiated monolayers were composed of predominantly stem cells, 






Figure 2: Mouse Enteroid Monolayers 
A) Mouse jejunal monolayers display an increase in trans-epithelial electrical resistance (TER) that indicates confluence at 
values above 100 Ω٠cm2. The non-differentiated monolayers continue to increase in TER until a stable point is reached. 
Experiments are performed when TER is stable for at least two days. Non-differentiated mouse jejunal monolayers display a 
lower TER than differentiated monolayers. Results are mean ± SEM. p-values are comparison of non-differentiated and 
differentiated enteroids on the same day post-plating.  Error bars not visible indicate an error smaller than the size of the 
point.  *p<0.0001, n=4 monolayers/condition. B-C) Confocal images (single slice XY at the apical surface and XZ views) of 
a non-differentiated (B) and a differentiated (C) mouse jejunal monolayer. Monolayers are a single layer of cells that display 
apical (WGA or SGLT1)-basolateral (Na+/K+ATPase) polarity. Cyan: Hoechst. Scale bars = 20µm B) Green: WGA (apical), 
Red: Na+/K+ ATPase (basolateral), C) Green: SGLT1 (apical), Red: Na+/K+ ATPase (basolateral) D) Fold change in mRNA 
of differentiated enteroids normalized to Rn18s expression/ ND monolayers. E) ΔCt for the expression of markers and genes 
of interest in ND and DF monolayers. Lower ΔCt value indicates higher expression levels. Non-differentiated (ND) mouse 
jejunum monolayers display proliferation and crypt markers in addition to low but detectable levels of markers for several 
differentiated populations by qRT-PCR. Differentiated monolayers (2 days) lose stem cell and crypt markers (Lgr5, Nkcc1, 
and Cftr) and have increased expression of villus cell markers (sucrase-isomaltase (Si), mucin 2 (Muc2), and Dra). The tuft 
cell marker Dclk1 and the intestinal epithelial marker villin (Vil1) are unaffected by differentiation. Normalized to Rn18s 
expression, n=3, points may overlap. F) Basal Isc in the non-differentiated jejunal monolayers is significantly higher than in 
the differentiated monolayers, p-value determined by Student’s paired t-test. Number of experiments (n) indicated below the 
bars. G-H) Differentiated jejunal monolayers exhibited reduced anion secretory response to G) carbachol [10μM] and H) 
forskolin [5μM] compared to the non-differentiated monolayers.  The number of experiments (n) is indicated under each bar, 
Student’s paired t-test used for statistical comparison. 
 
A) Mouse jejunal monolayers display an increase in trans-epithelial electrical resistance (TER) that indicates confluence at 
values above 100 Ω٠cm2. The non-differentiated monolayers continue to increase in TER until a stable point is reached. 
Experiments are performed when TER is stable for at least two days. Non-differentiated mouse jejunal monolayers display a 
lower TER than differentiated monolayers. Results are mean ± SEM. p-values are comparison of non-differentiated and 





As expected, monolayers maintained in the non-differentiated condition expressed high levels of 
the stem cell marker Lgr5, while the differentiated enteroids expressed multiple villus brush boarder 
enterocyte genes including sucrase-isomaltase (Si) and the goblet cell marker Muc2. Interestingly, the tuft 
cell marker, Dclk1, was expressed similarly in the non-differentiated and differentiated monolayers. 
mRNA expression of differentially expressed transporters also supported the non-differentiated versus 
differentiated state of the monolayers. Nkcc1 (a transporter expressed primarily in the crypts) and Cftr 
(expressed predominantly but not entirely in the intestinal crypt) exhibited reduced expression with 
differentiation. mRNA for transport proteins known to be expressed in the villi including the 
sodium/hydrogen exchanger 3 (Nhe3) and the chloride/bicarbonate exchanger downregulated in adenoma 
(Dra) were increased with differentiation (Figure 2D, E). The intestinal epithelial cell marker villin (Vil1) 
was unaffected by the differentiation status of the monolayers and confirmed that the monolayers did not 
lose their intestinal identity in culture. The increase in TER (Figure 2A) and changes in expression 
(Figure 2D, E) shows that these monolayers are differentiated and more similar to the jejunal villus while 
the non-differentiated monolayers are more representative of the intestinal crypt. It is interesting to note, 
that while mRNA expression displays the same directional trends in mouse jejunal enteroids as human 
duodenal enteroids, the average difference in expression between the two systems is different62. For 
example, in the mouse system, Dra expression is increased 10.5-fold with differentiation, but the average 
expression in human duodenum was over 20-fold increase with differentiation. Whether the differences in 
the change in expression are due to technical variation due to the differing primers used, differences 
caused by the culture and differentiation methods, or actual differences in expression between mouse and 
human tissues is unknown.  
The functional characterization of ion transport by the monolayers in the Ussing Chamber/ 
Voltage Clamp was determined. Both non-differentiated and differentiated monolayers were studied using 
the Ussing Chamber/Voltage Clamp method with basal short-circuit current (Isc) and response to forskolin 





intracellular cAMP. Carbachol on the other hand acts by activating Gq/11-coupled muscarinic receptors to 
increase intracellular calcium from the ER stores.  
Basal Isc was significantly lower in differentiated monolayers compared to non-differentiated 
monolayers (DF = 3.9µA/cm2 ±  0.8µA/cm2 versus ND = 18.1µA/cm2 ± 1.7µA/cm2, p=0.0002, n=5) 
(Figure 2F). The agonists had divergent effects when applied to monolayers grown in the two conditions, 
the non-differentiated monolayers displayed a larger magnitude of increased anion secretion (11.1µA/cm2 
± 1.9µA/cm2, n=5)  in response to carbachol [10μM] than the monolayers that underwent differentiation 
(1.3µA/cm2 ± 0.58 µA/cm2, 14.7% ± 4.4% of the response in ND monolayers, n=5, p=0.0047) (Figure 
2G). Forskolin-induced current was also higher in non-differentiated monolayers (8.7µA/cm2 ± 
0.58µA/cm2, n=3) when compared to differentiated monolayers (5.3µA/cm2 ± 0.25µA/cm2, 61.0% ± 
3.8% % of the response in ND monolayers, p=0.039, n=3) (Figure 2H).  
C. Discussion 
Mouse enteroid monolayers were generated by altering both the filter coating and media 
composition when compared to that used when generating human enteroid monolayers, which was used 
as a baseline to optimize the protocol15.  The key modifications that allowed reproducible production of 
murine monolayers included: 1) Coating filters with a high concentration (200μg/mL) of rat tail collagen I 
instead of 34μg/mL of human placental collagen IV; 2) Removing the TGFβ1 receptor inhibitor A83-01, 
which prevents monolayer formation when present in the media; and  3) Using non-enzymatic methods to 
passage the cultures, as enzymatic digestion with TrypLE, Accutase, and Trypsin all prevented the 
formation of confluent monolayers. These monolayers could be maintained in a non-differentiated state or 
differentiated following the protocol published by Kozuka et. al.58  
Mouse jejunal monolayers that underwent the defined differentiation protocol displayed several 
traits inherent to differentiated intestinal epithelium. Trans-epithelial resistance increased significantly 
after two days of differentiation. Molecular markers of differentiation cell types increased as did ion 





proliferating and crypt ells were lost. Finally, transport behavior of the differentiated cultures displayed 
reduced secretory responses after stimulation with either forskolin or carbachol, a mark of differentiation 
in both tissue and other intestinal epithelium cell models. This demonstrates the validity of the 
differentiation model described for mouse enteroids as a model for the intestinal villus and the non-
differentiated enteroids as a model of the intestinal crypt.  
Mouse enteroids studied as confluent monolayers now can be used in a similar manner as human 
enteroids with the apical surface exposed to allow studies that include transcytosis of luminal or 
basolateral nutrients, separate effects of neurohumoral substances on the apical and basolateral surfaces, 
lumen specific effects of commensal or pathogenic organisms, and characteristics of separate transport 








V. Cholinergic-induced anion secretion in mouse jejunal 
monolayers involves synergy between muscarinic and nicotinic 
pathways83 
A. Background 
Cholinergic signaling is one of the most widespread signal-transduction pathways in the human 
body, acting through either the G protein-coupled receptor (GPCR) muscarinic receptors or the ligand-
gated cation-channel nicotinic receptors43,63,92–95,84–91. The peripherally expressed muscarinic receptors 
have been thought responsible for terminal cholinergic effects, while the neuronal nicotinic receptors are 
thought to be involved with stimulating and transmitting action potentials.  
The mouse intestinal cholinergic response has been attributed to M3 and to a lesser extent M1 
muscarinic receptors45. Recently, however, nicotinic receptor subunit expression was identified in mouse 
intestinal enterocytes, the presence of which was confirmed at the message level in mouse enteroids96–99. 
Single cell mRNA sequencing of the mouse intestinal epithelium indicated that the previously published 
data were incomplete97. One example being that the nicotinic subunit Chrnb1 was shown to be expressed 
at low levels by almost all cell types of the intestinal epithelia, but the subunit had previously been 
considered exclusive to neuromuscular junctions. Nicotinic subunit expression is also present in several 
intestinal cancer cell lines and other epithelia (mouse colonic epithelia100,101, HT29102, STC-1 cells103, 
airway epithelia104, skin keratinocytes105). The full spectrum of nicotinic subunit expression in intestinal 
epithelial cells is still undergoing evaluation. 
Until recently, a physiological function of the nicotinic receptors in the intestinal epithelia was 
not reported. A link between nicotinic receptor activation and Wnt-signaling that regulates proliferation 
and differentiation of the intestinal epithelia was recently made using mouse enteroids, specifically the 
nicotinic antagonist Mecamylamine reduced growth of 3D organoids over 7 days96, but other possible  





nicotinic receptors being limited to the nervous system and specific cell types means that any data 
supporting nicotinic receptor function in terminal tissues is rare and may be mistakenly attributed to 
muscarinic receptor activation. This occurs since most studies model cholinergic regulation using the 
agonist carbachol, which activates both muscarinic and nicotinic receptors, and data are interpreted 
assuming the absence of nicotinic receptors.  
The non-differentiated crypt model we developed was used for further analysis of cholinergic-
induced anion secretion as the intestinal crypt where a majority of anion secretion is known to occur62. 
This is in contrast to whole tissue and animal models where the crypt and villus populations are both 
present during studies. One benefit of the enteroid cultures over these other models is that there are no 
contaminating cell populations so that epithelial contributions can be defined.  As demonstrated by our 
following cholinergic findings, the enteroid monolayer system provides a unique platform to study 
physiology that may otherwise be masked by the complexity of whole tissues.   
B. Results 
1. Cholinergic-induced anion secretion is partially hexamethonium sensitive 
Since the differentiated monolayers have characteristics of the jejunal villus and display the 
expected low anion secretion in response to carbachol (<2μA/cm2), the non-differentiated monolayers 
were used for analysis of cholinergic-induced secretion (Figure 2G). The cholinergic stimulation of anion 
secretion was initially evaluated in the jejunal enteroid monolayers using the mixed muscarinic and 
nicotinic agonist carbachol (CCh). Short-circuit current (Isc) is a measure of electrogenic ion transport 
across an epithelium. As the measurement is dependent on the injection of voltage to maintain the current 
across the epithelium at 0, transport that results in electroneutral ion movement (such as the exchange of 
one H+ for one Na+ by NHEs) is invisible to this system. The direction of the current change is dependent 
on the order of electrodes and orientation of the sample. In our preparation, a positive deflection 
represents either electrogenic apical anion secretion or cation absorption. Based on the previously defined 





secretion (in particular chloride secretion) was being observed.  Carbachol caused an increase in Isc that 
started immediately after addition to the serosal surface, peaked within 5 seconds, and lasted 
approximately 12 seconds total (Figure 3A). The effects of the cholinergic antagonists atropine 
(muscarinic) and hexamethonium (nicotinic) were evaluated on the carbachol response.  
In non-differentiated monolayers, the response to carbachol [10μM] was 25.35µA/cm2 ± 
1.28µA/cm2. Pretreatment with the muscarinic antagonist atropine [1µM] completely abolished the 
carbachol-induced secretion resulting in an increase in Isc of only 0.27µA/cm2 ± 0.23 µA/cm2 (1.0% ± 
0.9% of the control response, p<0.0001, n=3). Surprisingly, the nicotinic antagonist hexamethonium 
[10µM] significantly reduced the carbachol-induced short-circuit current to 14.9µA/cm2 ± 2.68µA/cm2 
(55.8% ± 9.4% of the control response, p=0.012, n=3) (Figure 3B). Based on this unexpected finding of 
a significant nicotinic component to the carbachol response, in the absence of a neuronal population in the 


































Figure 3: Cholinergic Stimulation Increases Isc and is Atropine and Hexamethonium Sensitive  
A) Example traces of carbachol-induced anion secretion after 20 minute pre-incubation with hexamethonium [10μM] or 
atropine [1μM] in non-differentiated mouse jejunal enteroid monolayers. The arrow indicates addition of CCh [10μM]. B) The 
average increase in short circuit current (Isc) after stimulation with 10μM carbachol ± SEMs. Points indicate average values for 
individual experiments. Total number of experiments (n) for each condition included in the labels below the bars. p-values were 
calculated using an unpaired Student’s t-test between the carbachol [10μM] alone and pre-treatment with the cholinergic 







Fold change in mRNA expression of A) the muscarinic receptors and B) the nicotinic receptor subunits in mouse jejunal enteroid 
monolayers. Expression of non-differentiated monolayers set as 1.00 and expression in differentiated monolayers in comparison 
to non-differentiated presented as shaded bars. Expression of Chrm5 is reduced in differentiated monolayers, the other four 
muscarinic receptors are unaffected. Nicotinic alpha subunits 1, 3, and 7 are not expressed in the jejunal monolayers at all, and 
alpha subunits 5 and 6 are reduced in differentiated cultures. C) Delta Ct showing approximate mRNA expression comparisons of 
the cholinergic receptors in non-differentiated and differentiated monolayers. Corrected to Rn18s endogenous control expression 
(n=3-6 different passages). p-values were calculated using an unpaired Student’s t-test. 





2. Expression of cholinergic receptors in mouse jejunal enteroid monolayers  
The monolayers were tested for expression of nicotinic receptor subunits. Primers for each of the 
21 mammalian cholinergic receptor genes (5 muscarinic and 16 nicotinic) were used for qRT-PCR with 
cDNA isolated from both non-differentiated and differentiated mouse jejunal monolayers. All five 
muscarinic receptors were detectable in both differentiated and non-differentiated enteroids, although as 
previously reported, the M3 receptor was most highly expressed and only the M5 receptor was 
significantly altered with differentiation, being reduced to 49% ± 8.7% (p=0.0002) of expression in non-
differentiated monolayers (Figure 4A, C). Only three nicotinic subunits were not expressed in non-
differentiated or differentiated enteroids: cholinergic nicotinic subunit alpha 1 (Chrna1), nicotinic subunit 
alpha 3 (Chrna3), and nicotinic subunit alpha 7 (Chrna7). A majority of the receptors and subunits did 
not display a significant difference in mRNA expression between the non-differentiated and differentiated 
cultures. The nicotinic subunits that changed in expression upon differentiation, being lower in the 
differentiated enteroids were Chrna5 (53% ± 14%, p=0.0032) and Chrna6 (51% ± 9.1%, p=0.0003)  
(Figure 4B).  
As a variety of nicotinic receptor subunits were present in our culture model, we hypothesized 
that there was a previously uncharacterized nicotinic component to cholinergic-induced anion secretion 
that was being inhibited by pre-treatment with hexamethonium.  
3. Muscarinic stimulation is concentration dependent while nicotine has no effect on Isc  
In order to separate the contributions of the muscarinic and nicotinic components to cholinergic 
induced anion secretion, specific muscarinic (bethanechol) and nicotinic (nicotine) agonists were used. 
Stimulation of the mouse jejunal enteroid monolayers with the muscarinic-selective agonist bethanechol 
resulted in a concentration-dependent increase in Isc that mimicked the timescale and shape of the 
carbachol response (Figure 5A). Kinetic analysis using the Lineweaver-Burk method revealed a Km of 





In contrast, the addition of nicotine alone at concentrations from 3-30µM to the basolateral 
chamber did not significantly alter Isc (Figure 6A), and at high concentrations (≥100µM) there was a 
hexamethonium-insensitive drop in Isc that was attributed to toxicity (data not shown).  
4. Nicotine increases Isc when co-applied with bethanechol  
To determine if nicotine enhanced the muscarinic response, as indicated by the hexamethonium 
sensitivity of carbachol, the reconstruction of the carbachol response was tested by co-administering 
bethanechol and nicotine at various concentrations. Bethanechol (BCh) and nicotine (Nico) were applied 
to the basolateral surface of jejunal monolayers both separately and together. When applied together with 
30μM BCh, the addition of increasing concentrations of nicotine that were below the toxic dose resulted 
in an increased Isc compared to 30μM BCh alone (Figure 6B-D). The nicotine component was 
A) Example traces and B) Mean changes ± SEMs showing a 
concentration-dependent increase Isc in response to bethanechol 
stimulation. Points indicate individual traces, bars represent 
mean ± SEMs. Error bars not visible are covered by the points 
on the graph.  Statistical comparison was by one-way ANOVA 
with Tukey correction for multiple comparisons, p=0.0035. Total 
number of experiments (n) for each condition is listed below the 
axis. C) Kinetic analysis for bethanechol, Km = 91.5µM. 





concentration dependent at this BCh concentration only. Kinetic analysis of the nicotine-induced increase 
in BCh-induced Isc for 30µM bethanechol (corrected by subtracting the bethanechol response without 
nicotine application before analysis with the Lineweaver-Burk method) indicated a Km of the nicotine 
component of 7.4µM (Figure 6E). Of note, a significant effect due to the addition of nicotine was not 
detected when applied with either 10µM or 100µM bethanechol. 
5. Muscarinic and nicotinic synergy is hexamethonium sensitive 
To demonstrate that the muscarinic and nicotinic components were mediated by the muscarinic 
and nicotinic receptors rather than an off-target response to the agonists, the combination of bethanechol 
and nicotine was tested for sensitivity to the antagonists atropine [1μM] and hexamethonium [10μM]. 
Pre-incubation with hexamethonium [10µM] reduced the synergistically-induced Isc to the same level as 
BCh [30µM] alone, and pre-incubation with atropine completely abolished the anion-induced secretion as 
expected (Figure 7). This indicates that the synergy is mediated through both types of receptors rather 
than a non-receptor mediated pathway.  
A) Without BCh, nicotine exhibits no significant effect on Isc. B-D) 
Synergy between various concentrations of nicotine and B) 10μM, 
C) 30μM, and D) 100μM of BCh. Points indicate individual traces, 
bars represent mean ± SEMs. Total number of experiments (n) for 
each condition is listed under each axis. For nicotine plus 30μM 
BCh, p-value for 30μM BCh conditions was calculated using one-
way ANOVA with Tukey’s correction for multiple comparisons. E) 
Kinetic Analysis for nicotine. The Km for the synergistic increase in 
Isc caused by nicotine (calculated as the increase in Isc caused by 
BCh [30μM] plus nicotine [0-30μM], minus the increase in Isc by 
BCh alone [30μM]) = 7.4μM.   
Figure 6: The Increase in Isc in Response to Various 







The present study offers two significant findings: first is the observation of a previously 
uncharacterized component of cholinergic signaling in the intestinal epithelia through nicotinic ligand-
gated cation channels and second is the development and characterization of a mouse enteroid monolayer 
system. While human enteroid monolayer studies have advanced gastrointestinal physiology and 
pathophysiology, problems with generating mouse enteroid monolayers have held the field back. Here we 
demonstrate successful, reproducible generation of confluent monolayer cultures using mouse enteroids. 
These cultures reveal a previously uncharacterized aspect of cholinergic-induced anion secretion, offering 
an important tool to further advance the field of gastrointestinal physiology. 
This study applies the newly developed mouse enteroid monolayers to identify and characterize a 
functional nicotinic component of epithelial cholinergic-induced anion secretion that was previously 
masked by both the systems available and the assumptions made by the community. In challenging the 
current dogma regarding the presence of functional nicotinic receptors outside of select cell populations 
A) Traces from a single experiment (arrow indicates addition of agonist) and B) The mean maximum increase in Isc in the 
presence and absence of simultaneous administration of nicotine; in some cases after pre-treatment (20 min) with serosal 
hexamethonium [10μM] or atropine [1μM]. Hexamethonium eliminated the synergistic increase in Isc caused by BCh and 
nicotine. The elimination of the nicotinic component restored anion secretion to levels comparable to when stimulated with 
bethanechol[30μM] alone. Bars represent mean ± SEMs. p-values calculated by unpaired Student’s t-tests between indicated 
conditions. Total number of experiments (n) for each condition listed under each bar. 





and functions, we open the door to investigation of potential localization and functions in even more cell 
populations. Due to the widespread nature of nicotinic receptors within the body, there is clinical 
application in determining the extent of localization and function to address potential diseases, treatments, 
and side effects that may have been overlooked due to the masked nicotinic component of cholinergic 
signaling.  
In the intestinal epithelia, it has been well documented that muscarinic receptor M3 is responsible 
for a large outward current in response to acetylcholine, causing an efflux of chloride and fluid into the 
lumen of the intestine. In the mouse, this is supplemented by the M1 receptor45, but in the human small 
intestine only M3 mediates anion secretion. The current model of intestinal cholinergic-induced anion 
secretion involves muscarinic receptors activating the Gq/11 signaling cascade to initially increase 
intracellular calcium release from ER stores to open apical chloride channels and activate plasma 
membrane K+ channels. Our results do not contradict this model but identified that cholinergic anion 
secretion also involves nicotinic receptors in the intestinal epithelial cells.  This conclusion is based on 
studies using mouse enteroids that are an exclusively epithelial cell model that lacks any component of 
the enteric nervous system or underlying muscle. 
The current results demonstrate that multiple nicotinic receptor subunits are expressed in mouse 
jejunal enterocytes. Expression of the full panel of nicotinic receptors has not previously been reported in 
the mouse jejunum, and the majority of nicotinic receptor studies have been done in colon cancer cells 
lines that express only a subset of the nicotinic subunits100–103. We demonstrated that a majority (13/16 
subunits) of the nicotinic subunits were expressed by the mouse jejunal epithelial cells, allowing for a 
large array of potential nicotinic receptors to compliment the known expression of muscarinic receptors. 
The variety of nicotinic subunits expressed by the mouse intestinal epithelial monolayers indicates that 
there may be nicotinic-mediated effects on many processes that have not previously been 
considered96,99,106. Determining which nicotinic pentamer is responsible for the effect on anion secretion 





Recently, murine small intestinal epithelial single cell mRNA sequencing data was reported, 
which expanded our knowledge of the nicotinic receptor genes that are expressed by intestinal 
epithelium97. This study identified 5 out of 16 mammalian receptor subunits, Chrna2, Chrnb1, Chrnb2, 
Chrnb4, and Chrne. The mRNA expression data from the enteroid monolayers identifies an even larger 
pool of nicotinic subunits (13/16).  
The unexpected and significant inhibitory effect of hexamethonium on carbachol-induced anion 
transport in the enteroid monolayers indicated a likely role for nicotinic receptors expressed by the 
intestinal epithelia having a modulatory role on muscarinic-induced Isc. Nicotine-induced nicotinic 
signaling, although it had a significant effect on cholinergic-induced anion secretion when inhibited, did 
not have an effect on short-circuit current when nicotine was applied independently. Rather, muscarinic 
activation with bethanechol was required to reveal the effect of nicotine on Isc, and the co-application of 
nicotine enhanced bethanechol-induced anion secretion in a concentration dependent manner, an effect 
that was hexamethonium sensitive and thus mediated through the nicotinic receptors. Why nicotine has a 
synergistic effect at only an intermediate bethanechol concentration is not understood; although the lack 
of any additional effect of nicotine at the maximal bethanechol concentration likely indicates saturation of 
some aspect of the anion secretory process involved.  
Taken together, the partial inhibitory effect of hexamethonium and the lack of nicotine-induced 
Isc indicates that nicotinic signaling does not play a primary role in secretion, but rather a modulatory one. 
It appears to act to further increase anion secretion only if anion secretion is already occurring in response 
to muscarinic activation.  
The cholinergic response of the intestinal epithelia was initially characterized in T84 
cells40,47,50,107–109, which has subsequently been used as a model of the anion secretory response. The 
current study shows that in mouse jejunal enteroids, the cholinergic signaling pathway is more complex, 
and opens the door to considerations that the cholinergic signaling pathways may be regulated in this 





mechanistic investigation. In addition, it is important to consider differences in normal intestinal models 
compared to studies using cancer cell lines. 
The isolated jejunal epithelial population cultured as monolayers allowed us to establish that 
nicotinic receptors are expressed by mouse intestinal epithelial cells and are involved in regulating anion 
secretion in response to cholinergic stimulation. As demonstrated by our cholinergic findings, the enteroid 
monolayer system provides a unique platform to study physiology that may otherwise be masked by the 
complexity of whole tissues.  Mouse enteroids studied as confluent monolayers now can be used in a 
similar manner as human enteroids with the apical surface exposed to allow studies that include 
transcytosis of luminal or basolateral nutrients, separate effects of neurohumoral substances on the apical 
and basolateral surfaces, lumen specific effects of commensal or pathogenic organisms, and 
characteristics of separate transport processes present on the apical and basolateral surface. Further 
mechanistic understanding of the synergistic interactions of the muscarinic-nicotinic signaling pathways 





VI. Mechanism of cholinergic synergy in jejunal anion secretion 
A. Background 
 The previously described observation of a nicotinic component of anion secretion that is 
dependent on muscarinic-induced secretion leads to the conclusion that there must be cross-talk between 
the two pathways. The literature regarding nicotinic-modified anion secretion in the small intestine is 
limited by being a novel observation, but cross-talk between the two pathways in other systems is also 
poorly defined. The current dogma of muscarinic and nicotinic receptors being expressed by mutually 
exclusive cell types has recently been called into question by observations in many systems100,102–105,110; 
but any functional physiology involving the two is still newly observed and poorly defined. In order to 
characterize the intracellular signaling pathways that are involved in the cross-talk of cholinergic 
muscarinic and nicotinic receptors as involved with cholinergic-induced anion secretion, we continued to 
utilize our newly defined mouse enteroid monolayer system in order to 1) define the ions and transport 
proteins involved and 2) begin to define the mechanism by which the two pathways interact. 
 The cholinergic stimulation of secretion in the intestinal epithelium was previously defined in 
T84 cell monolayers. It was determined that not only are these cell responsive to carbachol, but the 
response was mediated by net chloride secretion and independent of an increase in intracellular cAMP, 
the pathway defined as responsible for VIP- and PGE-induced secretion36,44. Additionally, basolateral 
potassium was shown to play a key role both in chloride loading and maintaining the electronegativity of 
cells in both pathways35.  
It was thought that the activation of cholinergic-induced secretion was fairly straightforward due 
to the assumption of muscarinic signaling being responsible for activating an apical CaCC via ER calcium 
stores increasing intracellular calcium111,112. The identification of a nicotinic component does not directly 
conflict with this understanding, as it is a ligand gated calcium channel and activation of the pathway 





activation of CaCCs. However, confirming the mechanism by which the two pathways act to 
synergistically increase Isc is the next step.  
In our earlier work we demonstrated that muscarinic and nicotinic signaling pathways are likely 
to converge rather than act in a parallel fashion as the response could be saturated by bethanechol alone 
with no further increase in response from the addition of nicotine to a maximal dose of bethanechol 
(Figure 6D). We also know that whatever pathways are involved, the nicotinic pathway does not 
stimulate anion secretion when applied alone, the concurrent addition of bethanechol is required to see 
any effect of nicotine on anion secretion, indicating that nicotinic signaling likely acts as a positive 
modifier of muscarinic-induced Isc (Figure 6). Starting with these two observations, we proposed to 
determine the mechanism of intracellular cross-talk between the muscarinic and nicotinic pathways. 
 Previous observations indicate that cholinergic-induced secretion in the intestine is a result of 
chloride efflux into the lumen. Currently, electrogenic chloride efflux can be attributed to contribution(s) 
from two different chloride channel classes expressed on the apical surface of the mouse jejunum; the 
cystic fibrosis transmembrane regulator (CFTR) and calcium-activated chloride channels (CaCCs)111. 
CFTR is a well-known channel involved in chloride secretion in many secretory tissues. On the other 
hand, the exact member of the CaCC family involved in anion secretion in the mouse jejunum is still 
debated, with early evidence pointing to different isoforms being dominant in different regions of the 
intestine in the mouse113,114. 
The two classes of chloride channel are moderated by different intracellular signaling pathways, 
and knowing which channel is involved with the muscarinic and nicotinic components of secretion will 
help identify the mechanism of intracellular cross-talk that mediates the nicotinic modulation of 








1. Inhibition of potassium channels abolishes CCh-induced Isc 
 To confirm that cholinergic-induced Isc is generated as result of apical chloride efflux rather than 
movement of a different ion, we tested the effect of inhibiting basolateral potassium channels—
responsible for potassium efflux that maintains electronegative status of the epithelial cells, facilitates 
chloride loading into the cell, and serves as a driving force for anion secretion, including chloride.   
 The initial peak of CCh-induced Isc (24.00µA/cm2 ± 4.06µA/cm2) was completely abolished by 
inhibition of the basolateral potassium channels with Clotrimazole [30μM] 1.86µA/cm2 ± 1.37µA/cm2 
(p=0.0067, n=3) (Figure 8-Red). Interestingly, the second phase of the response—the plateau phase—
remained unaffected by basolateral potassium channel inhibition. Only when monolayers were treated 
with clotrimazole apically either alone or in combination with basolateral inhibition were both peaks 
abolished (Table 7). 
 Time-to-resolution analysis of the initial peak confirms that the second phase and return to 
baseline of the cholinergic response is unaffected by potassium channel inhibition in general (Figure 8D), 
while area-under-the-curve (AUC) analysis demonstrates that losing only the peak current with 
basolateral potassium channel inhibition leaves a majority of chloride secretion intact in the second phase 
(66.9% of CCh control).  
When apical potassium channels are inhibited, both peaks are affected and only 32.6% of total 
chloride secretion remains. Inhibition of potassium channels on both the apical and basolateral 
membranes together had a slightly smaller effect on AUC, leaving 49.3% of chloride secretion remaining, 
likely due to higher variability in the dual-inhibited condition (Figure 8E). This supports the observation 
that apical chloride secretion is responsible for the cholinergic-induced Isc observed and demonstrates that 
rather than being driven by a single, basolateral potassium channel, chloride secretion has two phases 
mediated through two potassium channels located on opposite sides of the polarized cell. The novel 





response we observed, indicates that our understanding of the mechanism of chloride secretion in the 
intestinal epithelium is incomplete. 
 
 
A) Average traces (arrow indicates addition of CCh[10μM]), and the mean maximum increase in B) the initial Isc peak 
and C) the second phase peak in the presence and absence of the potassium channel inhibitor Clotrimazole[30μM] 
applied serosally, mucosally, or both. D) The average amount of time before cholinergic-induced Isc returned to baseline. 
In all conditions, the experiment was ended before Isc returned to 0. E) The average AUC indicating total secretion post-
crbachol stimulation. Only when apical potassium channels were inhibited was total secretion significantly reduced. Pre-
incubation (15 minutes) with Clotrimazole[30μM] basolaterally abolished the initial peak of CCh-induced Isc but the 
plateau phase was unaffected. Pre-incubation with apical clotrimazole or the combination of apical and basolateral 
clotrimazole blocked both peaks.  p-values were calculated using an unpaired Student’s t-test comparing conditions to B) 
CCh alone or C) basolateral clotrimazole treatment. Points represent individual traces while bars denote the average and 
























































































2. Carbachol-induced anion secretion is mediated through CFTR and CaCC 
 The contribution of two different chloride channels to cholinergic-stimulated anion secretion was 
evaluated in the jejunal enteroid monolayers using the mixed muscarinic and nicotinic agonist carbachol 
(CCh), the muscarinic-specific agonist bethanechol (BCh), and the nicotinic-specific agonist nicotine 
(Nico). The inhibitor BPO27 was used to block any chloride secretion through CFTR. The CaCC 
inhibitor A01 was used to block contributions of this channel family to CCh-induced chloride secretion.  
Inhibition of carbachol-induced chloride secretion using either the CFTR inhibitor BPO27 or the 
CaCC inhibitor A01 was used to determine the identity of the chloride channel(s) involved in the 
cholinergic-induced increase in Isc. Carbachol caused an increase in Isc similar to that defined previously 
(Figure 9). The effects of chloride channel antagonists BPO27 and A01 were evaluated on the CCh 
response [10μM] in non-differentiated mouse jejunal monolayers. The carbachol response (27.46µA/cm2 
± 5.5µA/cm2, n=5) was blunted by 20 minute pre-treatment with the CFTR inhibitor BPO27 
10.23µA/cm2 ± 4.4µA/cm2 (31.29% ± 8.0% of the control response, p<0.0001, n=3) or the CaCC 
inhibitor A01 9.9µA/cm2 ± 1.7µA/cm2 (44.5% ± 11.2% of the control response, p=0.0004, n=4). 
Application of both inhibitors abolished CCh-induced Isc, 1.0µA/cm2 ± 0.15µA/cm2 (6.5% ± 0.4% of the 
control response, p<0.0001, n=3). Altogether, this data indicated that cholinergic-induced anion secretion 
is mediated by both CFTR and a CaCC. 
 
Condition Peak 1 Peak 2 
Carbachol[10μM] 24.00µA/cm2 ± 4.06µA/cm2 
N/A 
Clotrimazole[30μM]BL 
1.86µA/cm2 ± 1.37µA/cm2 
p=0.0067, n=3 
4.95µA/cm2 ± 0.61µA/cm2 
Clotrimazole[30μM]AP 
-1.97µA/cm2 ± 0.30µA/cm2 
p=0.0031, n=3 
1.30µA/cm2 ± 0.16µA/cm2 
p=0.0043, n=3 
Clotrimazole[30μM] 
-3.92µA/cm2 ± 0.94µA/cm2 
p=0.013, n=2 
2.10µA/cm2 ± 0.05µA/cm2 
p=0.036, n=2 
 
Average maximum short-circuit current peaks for the initial peak and secondary peak post-carbachol[10μM] stimulation 
with and without clotrimazole[30μM] pre-incubation (15 minutes) as indicated. 





3. Bethanechol- and nicotine-induced secretion is mediated through CFTR and CaCC 
Inhibition of chloride secretion in response to the combination of BCh[30μM] + Nico[30μM] 
after pre-incubation with either the CFTR inhibitor BPO27 or the CaCC inhibitor A01 was tested to 
confirm that the combination of agonists is acting through the same channels as the mixed agonist 
carbachol. The combination of bethanechol and nicotine caused an increase in Isc (10.16µA/cm2 ± 
1.7µA/cm2, n=9) that was greater than that of BCh alone (61.6% ± 10.0% of the control response, 
p<0.0001, n=5) and was blunted by 20 minute pre-treatment with the CFTR inhibitor BPO27 7.07µA/cm2 
Stimulation of non-differentiated jejunal monolayers with a general cholinergic agonist (CCh[10μM]), muscarinic 
agonist (BCh[30μM]), or a combination of muscarinic and nicotinic agonists (BCh[30μM]+Nico[30μM]) after pre-
incubation with either a CFTR inhibitor (BPO27) or a CaCC inhibitor (A01). Stimulation with CCh and BCh+Nico give 
similar inhibition profiles with BPO27 and A01 partially inhibiting Isc and pre-incubation with both abolishing Isc. BCh-
stimulated Isc is unaffected by BPO27 alone, but the CaCC inhibitor A01 only partially inhibits Isc. Inhibition of both 
CaCC and CFTR abolished BCh-induced Isc. p-values were calculated using an unpaired Student’s t-test between the 
control condition of the agonist alone and pre-treatment with the chloride channel inhibitors, *p<0.05. Dots represent 
individual traces while bars denote the average and SEM for each condition.  





± 2.1µA/cm2 (57.41% ± 6.6% of the control response, p<0.0001, n=3) or the CaCC inhibitor A01 
7.0µA/cm2 ± 0.5µA/cm2 (53.0% ± 3.9% of the control response, p<0.0001, n=4). Application of both 
inhibitors abolished BCh+Nico-induced Isc, 1.0µA/cm2 ± 0.4µA/cm2 (29.6% ± 10.6% of the control 
response, p<0.0001, n=5) (Figure 9). This data shows that the combination of muscarinic (bethanechol) 
and nicotinic (nicotine) agonists phenocopies the chloride response of the cholinergic agonist carbachol as 
expected, and that cholinergic-induced chloride secretion is mediated through both CFTR and a CaCC.  
4. Bethanechol-induced secretion is primarily mediated through CaCC 
 Since nicotine does not elicit a change in Isc when applied alone, determining which channels are 
activated as a result of either muscarinic or nicotinic signaling must be done by comparing the responses 
of BCh-induced Isc to BCh+Nico-induced Isc. Whatever is different between the two can be attributed to 
the action of nicotinic signaling while the BCh-induced current demonstrates the activity resultant from 
muscarinic signaling.  
BCh-induced current (11.7µA/cm2 ± 2.1µA/cm2, n=7) was unaffected by pre-incubation with 
inhibitor BPO27 10.75µA/cm2 ± 2.5µA/cm2 (112.5% ± 23.0% of the control response, p=0.5445, n=6) 
and only partially inhibited by inhibitor A01 7.2µA/cm2 ± 1.3µA/cm2 (71.8% ± 6.7% of the control 
response, p=0.0002, n=5). Application of both inhibitors abolished BCh-induced Isc, 1.2µA/cm2 ± 
0.3µA/cm2 (14.0% ± 4.1% of the control response, p<0.0001, n=5) (Figure 9). The lack of a CFTR 
component in response to BCh stimulation alone indicates that the nicotinic pathway modifies 
muscarinic-induced Isc by regulating the activation of CFTR which possibly occurs via inducing cross-
talk between [Ca2+]i and cAMP. The incomplete abolishment of BCh-induced current by A01 indicates 
that a separate, secondary pathway may be involved when muscarinic-induced secretion fails—the cell 
partially activating CFTR in response to the inhibited CaCCs would explain why the CaCC-mediated 






5. Expression of chloride channels in mouse jejunal monolayers 
  As both CFTR and CaCCs appear to be involved in cholinergic induced anion secretion, we 
checked mRNA expression in both ND and DF mouse jejunal monolayers for Cftr and two CaCC 
isoforms previously shown to be involved in intestinal chloride secretion in the mouse113–115. In mouse 
jejunal monolayers, Cftr expression is reduced in DF monolayers compared to ND monolayers 
(p<0.0001), is higher than Ano1/Tmem16A expression in ND monolayers (p<0.0001) but is comparable to 
Ano6/Tmem16F in ND monolayers (p=0.09). In differentiated monolayers, Cftr expression is comparable 
to Tmem16A (p=0.11) but lower than Tmem16F (p<0.0001). In fact, while both Cftr (p<0.0001) and 
Tmem16A (p=0.0011) expression decreased with differentiation, Tmem16F increased with differentiation 
(p=0.0008) (Figure 10). Overall, Tmem16F is more highly expressed in the mouse jejunum than 
Tmem16A, though both appear to be expressed at levels that could result in an observable increase in 
chloride transport as they are expressed in comparable levels to Cftr. This is partially corroborated by 
mRNA expression of apical chloride channels that may be involved in cholinergic secretion in mouse jejunal monolayers. 
CFTR is well defined as an apical chloride channel with functions in health and disease in the intestinal epithelia. TMEM16A 
and F are members of the calcium-activated chloride channel (CaCC) family that have been implicated in intestinal secretion. 
All three channels are expressed in both ND and DF mouse jejunal monolayers. Both Cftr and Tmem16A are reduced with 
differentiation (p<0.05, n=3) while Tmem16F expression is increased with differentiation of the jejunal monolayers (p<0.05, 
n=3). Mean and error bars indicating SEM not visible are covered by the points. Points indicate average expression (of 3 
replicates). 





studies in the literature describing segment specific expression of TMEM16 proteins in the intestine113,114. 
However, the lack of consensus regarding the validation of TMEM16 antibodies means that such studies 
should be considered carefully. Further confounding the situation is the fact that TMEM16F has several 
different functions reported. TMEM16F has been described as having flippase activity in platelets and 
mutations that result in the loss of flippase activity have been identified in patients with a rare bleeding 
disorder called Scott Syndrome116,117. Flippase function of TMEM16F in the intestine has not been 
investigated, but studies in other systems indicate that chloride channel activity and flippase functions 
may be independent of each other118,119. The literature regarding TMEM16F further confounds due to 
reports of cation channel function120,121. Thus we are faced with the possible conundrum of a single 
protein that acts as a flippase, an anion channel, and a cation channel all at once. Beyond TMEM16A, 
16B, and 16F, the remaining TMEM16 family members remain largely uncharacterized and their 
functions debated, thus residual chloride current may even be attributed to another family member yet 
characterized as their tentative classifications are so far by sequence homology only112.  
6. Intracellular calcium chelation reduces, but does not abolish carbachol induced Isc 
Interestingly, chelation of intracellular calcium using BAPTA-AM led to a significant reduction, 
but not abolishment of CCh-induced Isc 15.3µA/cm2 ± 4.0µA/cm2 (35.8% ± 8.6% of the control 
response, p<0.0001, n=3) (Figure 11A). This was unexpected as we had hypothesized that [Ca2+]i was the 
secondary signal responsible for the entirety of the response. The Isc remnant in the presence of BAPTA-
AM indicated either 1) BAPTA-AM chelation was incomplete in the conditions we selected and there 
was residual calcium in the system, 2) there was another contributing pathway that was calcium 
independent, or 3) there was an effect—that due to either close localization or rapid temporal effects—
was exerted on the system before the stimulated calcium could be chelated.  
In order to be sure that the partial BAPTA-AM effect on Isc was not due to incomplete calcium 
chelation or due to calcium effects prior to chelation, Caco-2 M3R/GCaMP6s monolayers were pre-





incubation time as when investigating transport, BAPTA-AM completely abolished both bethanechol- 
and bethanechol and nicotine-induced increases in intracellular calcium in the Caco-2 monolayers 
(Figure 11B-C). As intracellular calcium was successfully chelated and did not display any temporary 
increase in calcium levels, the residual Isc observed after chelation with BAPTA-AM is likely caused by a 
A) Stimulation of non-differentiated jejunal monolayers with a general cholinergic agonist (CCh[10μM]), 
muscarinic agonist (BCh[30μM]), or a combination of muscarinic and nicotinic agonists 
(BCh[30μM]+Nico[30μM]) after pre-incubation with the cell permeable calcium chelator BAPTA-AM [25μM] 
for 25 minutes. Stimulation with various cholinergic agonsits resulted in only partially inhibition of Isc. p-values 
were calculated using an unpaired Student’s t-test between the control condition of the agonist alone and pre-
treatment with the chelator, *p<0.05. Dots represent individual traces while bars denote the average and SEM 
for each condition. B-C) The average traces of calcium-induced F1/F0 after for stimulation of Caco-2 
M3R/GCaMP6s monolayers stimulated with B) BCh[0.5μM] or C) the combination of 
BCh[0.5μM]+Nico[10μM] either alone (LINE) or after 20 minutes pre-incubation with BAPTA-AM[25μM] 
(DOTS). The number of experiments averaged is indicated beneath each graph. Images acquired every second 
for 10.5 minutes and the entire frame averaged. Ionomycin[5μM] added after 500s as positive control. 





secondary signaling pathway upstream of the increase in [Ca2+]i. This indicates a calcium-independent 
component of muscarinic-induced secretion that was unaccounted for in our current understanding and 
requires further investigation.   
7. Nicotine has no effect on intracellular calcium 
It is known that muscarinic induced Isc is generated through an increase in [Ca2+]i from the ER 
stores through IP3R activation in response to Gq signaling. It is also known that many nicotinic ligand-
gated cation channels are strongly selective for calcium, though the exact selectivity is determined by the 
subunits which compose the final channel106. As such, we investigated whether there was a synergistic 
increase in [Ca2+]i  when both pathways were activated compared to muscarinic activation alone. 
Overexpression of both the cytosolic calcium sensor GCaMP6s and the M3 receptor in Caco-2 
cells (which do not endogenously express the M3 receptor) was used to image intracellular calcium in real 
time.  
It was determined that a non-saturating concentration of BCh[0.5μM] combined with a 
concentration of nicotine[10μM] that resulted in no measurable increase in calcium on its own (data not 
shown) indicates that nicotinic activation has no effect on intracellular calcium (Figure 11B and C, 
Figure 12A and B). Rather than the expected synergy causing an increase in intracellular calcium due to 
two distinct sources of calcium being activated, there was no difference in the average traces with or 
without nicotine in any metric tested (Figure 12C-F) nor did nicotine alone cause a visible response.  
It is possible that the mechanism regulating cross-talk between the two pathways involves a 
threshold of intracellular calcium that is met when both the M3 receptor and the nicotinic ligand-gated 
channels are activated while the nicotinic channels cause an increase in calcium that is undetectable by 
this sensor but that is unlikely. As a ligand-gated calcium channel, the nicotine-induced increase in the 
calcium response should in theory be near-immediate and very visible. Even discounting the fact that 
using the cytosolic GCaMP6S we were unable to detect an increase in [Ca2+]i after stimulation with 





apparent in conjunction with muscarinic stimulation. This leads us to conclude that the nicotinic 
mechanism of action is likely independent of its function as a cation channel and any increases in 
intracellular calcium are by muscarinic signaling alone. Despite this, it is clear that there is a nicotinic 
Figure 12: Cholinergic intracellular calcium responses  
Average traces of fluorescence stimulated in response to increased cytosolic calcium increase in response to A) 
BCh[0.5μM] and B) BCh[0.5μM]+Nico[10μM] with and without chelation of extracellular calcium via pre-treatment 
for 60s with 1.4mM EGTA as indicated. C) The average number of calcium peaks observed as calculated using the 
AUC analysis method in Prism 8/9. D) The average number of seconds post stimulation with the indicated agonist it 
took to reach the first calcium-induced peak. E) The average amplitude of the first calcium peak. F) The average AUC 
indicating total calcium response for each condition. A number of replicates did not indicate a calcium response and are 
represented by time to peak = 500s (end of the experiment) and all other values = 0. Points indicate values from 
individual experiments. Bars indicate SEM. p-values were determined by Student’s unpaired t-test and those trending 





effect on Isc (Figure 3, 6, and 7) indicating a possible function of the nicotinic receptors independent of 
their role as cation channels.  
8. Calcium sensitive adenylyl cyclase expression in mouse jejunal enteroids 
Given that CFTR is regulated primarily by cAMP while CaCCs are regulated by [Ca2+]i, we 
investigated the possible cross-talk between the two pathways in calcium sensitive adenylyl cyclases. 
Links between adenylyl cyclase, calcium microdomains, and anion secretion have been made after 
observations in mammalian disease and cell culture, offering a promising starting point for 
investigation122–128.  
Adenylyl cyclases (AC) are a class of enzymes that catalyze the conversion from ATP to the 
signaling molecule cAMP. There are ten isoforms of the enzyme, AC1-9 are membrane bound and AC10 
is cytosolic. AC1-9 are regulated through various methods, and several of them are known to be calcium 
inhibited or activated—either directly or through binding of calcium sensitive proteins like 
calmodulin127,129–132. Adenylyl cyclase 6 is the most highly abundant isoform in the intestinal epithelium 
and has been shown to be involved in intestinal secretion stimulated by both forskolin and cholera 
toxin133,134, but AC6 is described in the literature as inhibited both by calcium and Gαi subunits129. As 
such, we tested the mouse jejunal monolayers for expression of the putatively calcium-activated isoforms 
Adcy1, Adcy3, and Adcy8 in addition to Adcy6 for reference (Figure 13). It was found that expression of 
the adenylyl cyclase isoforms does not differ between non-differentiated and differentiated monolayers. 
Adenylyl cyclases 1 and 3 are below the detection limit, but Adcy8 is modestly expressed in the mouse 





Confirmation of the role of AC6 and AC8 in forskolin and CCh induced anion secretion will 
require future genetic knock down of both adenylyl cyclases as there are no inhibitors or antibodies 
specific enough for this purpose.  
9. Chelation of basolateral, but not apical, extracellular calcium blunts maximal CCh-
induced Isc 
 We hypothesized that not only were the intracellular ER calcium stores involved in regulating 
cholinergic-induced Isc, but the linked store operated calcium entry (SOCE) pathway was also involved. 
SOCE is directly downstream of calcium depletion in the ER, with calcium sensors on the ER membrane 
re-localizing and dimerizing when [Ca2+] is low within the ER. These dimers re-localize to the ER-plasma 
membrane junctions and bind to calcium-release activated channels (CRAC) channels of the ORAI 
mRNA expression of calcium activated adenylyl cyclases that may be involved in cAMP/calcium cross-talk in cholinergic 
secretion. Adcy1 and Adcy3 are below the detection limit, but Adcy8 was found to be expressed in both ND (black) and DF 
(white) monolayers. Adcy6 expression as a positive control in both conditions on the right. Expression normalized to Rn18s 
expression. The dotted line indicates the threshold of detection (normalized to Rn18s expression) for the system. Mean and 
error bars indicating SEM not visible are covered by the points. Points indicate average expression (of 3 replicates) in 3 
different passages. Missing points indicate mRNA expression was not detected in the sample. 
 






family. These channels on the extracellular membrane open and allow cations—primarily calcium—to 
enter the cell, further increasing cytosolic calcium135–142. 
 Chelation of extracellular calcium with EGTA [1.4mM] had no effect on peak Isc when applied to 
the apical chamber, 45.05µA/cm2 ± 9.9µA/cm2 (94.1% ± 5.7% of the control response, p=0.36, n=4)  
when compared to control monolayers in normal calcium conditions, 49.6µA/cm2 ± 8.2µA/cm2 (100.0% 
± 2.3% of the control response, n=4); however there was a significant decrease in peak Isc when EGTA 
was added to the basolateral chamber, but the peak is reduced only to 39.5µA/cm2 ± 6.9µA/cm2 (79.1% 
± 5.1% of the control response, p=0.0057, n=4) of control Isc (Figure 14A-D). This is far less of an effect 
Pre-incubation for 1 minute with EGTA [1.4mM] in either the apical or basolateral chamber before stimulation with 
CCh [10μM]. A-C) Average traces for mouse jejunal monolayers starting ten seconds before stimulation with carbachol 
and D) the mean peak increase ± SEM in Isc. Chelation of basolateral calcium blunts CCh-induced Isc while chelation of 
apical calcium had no effect on peak Isc. E) The average number of seconds it takes for Isc to return to baseline (y=0) 
after the CCh-induced peak ± SEM. F) The average total AUC of the cholinergic response indicating total chloride 
secretion for the duration of each experiment. G) The % AUC represented by the peak phase (defined as 0-26s with 
peaks aligned at 17s). p-values were calculated using unpaired Student’s t-test to compare conditions pre-incubated with 
EGTA as indicated to CCh alone as the control.  Points indicate individual traces, bars represent mean ± SEMs. 





than is observed when the nicotinic channels are inhibited by the antagonist hexamethonium (55.8%, 
Figure 3), contributing to the theory that the nicotinic mechanism is independent of its role as a calcium 
channel. However, this blunted effect is still less than expected based on the strong ties between the 
basolateral EGTA chelation inhibiting the muscarinic-induced increase in intracellular calcium and 
BAPTA-AM blunted Isc (Figures 11 and 12).  
In some cell types, CRACs have been observed expressed on serosal or basolateral surfaces of 
polarized cell types rather than apical/luminal surfaces143. SOCE is most well characterized in non-
polarized cells like lymphocytes and has not been well localized in native intestinal tissues yet. Due to the 
known localization of ER/PM interactions near the tight junctions, resolving the exact polarity of 
functional SOCE requires higher resolution than standard confocal methods. Co-expression analysis such 
as PLA assays (resolution to 40nm) and possibly even super-resolution methods may be required to 
definitely conclude the exact localization of the possible components, provided the sensors and channels 
involved are the same as defined for other SOCE activity. Functional analysis may be performed in the 
future using specific inhibitors of the various calcium channel families in the apical versus basolateral 
chambers to functional link Isc to both a specific channel type and confirm the polarity of distribution. 
10. Basolateral calcium chelation reduces total secretion and the return to baseline after 
CCh-induced stimulation 
In addition to the moderate reduction in peak current, there was a striking reduction in the time it 
took the CCh-induced current to return to baseline when basolateral calcium was chelated. A response 
that we had not observed in any of the previously tested conditions. To address this striking phenotype, 
alteration of the analysis method to include area-under-the-curve (AUC) and the time to resolution (Isc≤0) 
was performed on the previously acquired dataset. As the data were acquired for analysis with a different 
method in mind, the data is incomplete, but does demonstrate several trends when applied to various 






 The new metrics considered were the time it took for stimulated secretion to resolve, that is the 
time it took after reaching maximum Isc for the response to return to baseline (Isc≤0), and the total 
secretion calculated as AUC. As the maximal peak Isc was affected by many conditions tested, AUC was 
also normalized by dividing the peak AUC by the total AUC for each curve, generating a percentage of 
secretion attributed to both the peak and tail responses. When basolateral calcium was chelated with 
EGTA[1.4mM], the time to resolution was drastically reduced (25.3s ± 14s, p<0.0001, n=4) from the 
control traces which often did not reach resolution before the experiment was terminated (311s ± 24s , 
n=4) (Figure 14E). Similar to the control condition, chelation with apical EGTA[1.4mM] had no 
apparent effect on either phase under the tested parameters when compared to monolayers exposed to 
normal calcium conditions (313.0s ± 19s, p=0.9392, n=4). The AUC reflected this, chelation of 
basolateral calcium reduced total secretion and in particular it abolished the second phase, leaving a 
majority of secretion during basolateral EGTA chelation occurring during the initial, peak phase (87.2% 
± 4.5% of total secretion, p<0.0001, n=4) whereas the bulk of secretion in the control and apically 
chelated conditions occurred during the tail phase (peak phase secretion--control: 22.2% ± 4.5%, n=4 and 
apical EGTA: 21.5% ± 6.4%, p=0.9258, n=4) (Figure 14F and G). 
Overall, the proposed division of cholinergic secretion into two independent phases—an 
intracellular calcium dependent peak (Figure 11) and an extracellular Ca2+-dependent tail (Figure 14)—
has not previously been described in the intestinal epithelia and merits further investigation (Table 8).  
Initial Phase Secondary Phase 
Abolished by either apical or basolateral 
potassium channel inhibition (reduced 100%) 
Reduced by apical potassium channel inhibition 
only (reduced 74%) 
Reduced by BAPTA-AM (reduced 66%) Unaffected by BAPTA-AM (reduced 0%)  
Reduced by serosal EGTA (reduced 21%) Reduced by serosal EGTA (reduced 84%) 
 
Summary of data supporting a two-phase cholinergic-induced change in Isc 





11. Nicotinic signaling has an effect on the second secretory phase when chloride 
channels are blocked  
 To determine if any of the other conditions previously analyzed for maximal change in Isc display 
a quantifiable difference in either total secretion or in time to resolution, previous datasets were re-
analyzed. In response to stimulation with carbachol [10μM] (282s ± 43s, AUC = 305 ± 39, % peak AUC 
= 61% ± 3.1%, n=9): it was found that chloride channel inhibition of either CFTR (155s ± 40s, p=0.047; 
AUC = 174 ± 29, p=0.019; % peak AUC = 67% ± 4.8%, n=9), CaCC’s (173s± 38s, p=0.077, AUC = 90 
± 18, p=0.0002; % peak AUC = 61% ± 4.1%, n=9), or the combination (115s ± 47s, p=0.021; AUC = 23 
± 4, p<0.0001; % peak AUC = 34% ± 5.3%, p=0.0002, n=7) reduced the time it took to return to 
baseline and reduced total AUC (Figure 15A-C). Inhibition of CFTR or CaCCs alone had no significant 
effect on the initial peak AUC when data was normalized to account for the reduced maximum peak Isc, 
but the combination of CFTR and CaCC inhibitors resulted in a significantly reduced initial peak AUC 
that could not be entirely explained by the reduction of the initial peak.  
Supporting the hypothesis that extracellular calcium is responsible for the second phase effect, 
chelation of intracellular calcium with BAPTA-AM[25μM] did not appear to have any effect on either 
total secretion or time to return to baseline (284s ± 30s, p=0.9609; AUC= 204 ± 42; % AUC peak = 57% 
± 4.4%, p=0.7314, n=7), whereas BAPTA-AM chelation demonstrated the ability to significantly reduce 
initial peak Isc with an intracellular calcium independent remnant (Figures 11 and 14).  
Interestingly, these effects seem to be dependent on the activation of the nicotinic pathway, as 
monolayers stimulated with bethanechol [30μM] alone did not display the same trends in any condition. 
Inhibition of CFTR (343s ± 7.6s, AUC = , 158 ± 35, % AUC peak = 45% ± 3.9%, n=5), CaCC’s (322s 
± 16s, AUC = 151 ± 43, % AUC peak = 49% ± 4.8%, n=5), the combination (330s ± 9.8s, AUC = 132 
± 40, % AUC peak = 47% ± 6.7%, n=4), or chelation of intracellular calcium (318s ± 47s, AUC = 113 





compared to control monolayers (335s ± 39s, AUC = 166 ± 29, % AUC peak = 47% ± 3.5%,  n=5) 
(Figure 15 D-F). 
 Based on this data, it can be theorized that the nicotinic pathway influences more than just 
maximum peak Isc in cholinergic-induced secretion, but also influences the secondary phase. Specifically, 
the time it takes to return to baseline and total AUC demonstrate nicotinic-dependent effects on the 
second phase only after chloride channel inhibition, though the exact pathways involved in this regulation 
Pre-incubation for 25 minutes with the indicated inhibitor/combination before stimulation with CCh [10μM] (A and B) or 
BCh [30μM] (C and D). A) The average number of seconds it takes for Isc to return to baseline (y=0) after the CCh-induced 
peak ± SEM. B) The % AUC represented by the peak phase (defined as 0-26s with peaks aligned at 17s) divided by total 
AUC to normalize for variation in maximum peak response after CCh stimulation. C) The average number of seconds it 
takes for Isc to return to baseline (y=0) after the BCh-induced peak ± SEM. D) The % AUC represented by the peak phase 
(defined as 0-26s with peaks aligned at 17s) after BCh stimulation. p-value calculated using Unpaired Student’s t-tests 
compared to CCh or BCh alone as the control. Points indicate individual traces, bars represent mean ± SEMs.  





are unknown at this time. Further studies would require investigating the possible role of nicotinic 
signaling in the down-regulation of cholinergic-induced anion secretion as well as the mechanism of the 
second phase of secretion to determine the second-phase effect of nicotinic signaling. 
C. Discussion 
  Using the non-differentiated enteroid monolayer system to determine the components involved in 
cholinergic-induced anion secretion we confirmed that chloride is the major anion involved when the 
basolateral potassium channel that drives chloride flux is inhibited resulted in inhibition of the initial peak 
of carbachol induced Isc. There is some data supporting the presence of an apical potassium channels in 
the rat colon and a rat small intestinal cell line IEC-18, but its role in cholinergic anion secretion in the 
small intestine has not been observed until now144,145. This finding indicates that we are missing an entire 
component to our understanding of the regulation of the chloride secretion, adding a new consideration to 
both basic and clinical understanding of the chloride secretory pathway.  
It was also determined that both CFTR and CaCC class transporters are involved in the apical 
efflux of chloride in response to mixed cholinergic signaling. When the physiological response is broken 
down into muscarinic and nicotinic components, it was observed that muscarinic-induced signaling 
results in a primarily CaCC-mediated efflux as inhibition of CFTR has no effect on Isc when only the 
muscarinic pathway was activated. Interestingly, there is a secondary pathway where CFTR was partially 
activated, but only when the CaCCs were inhibited. Only by inhibiting both anion channels was the initial 
peak abolished after muscarinic stimulation. These two findings together indicate that nicotinic signaling 
is activating CFTR. 
 Since there are many isoforms of CaCCs, the two most likely candidates were screened for 
mRNA expression in the monolayer system. In the mouse jejunal tissue, TMEM16F was shown by 
genetic knock-down to be involved in anion secretion while TMEM16A performed the same function in 
the mouse colon113–115,146. Both CaCCs were shown to be functionally linked to CFTR and involved in the 
regulation of chloride secretion via calcium signaling. In the jejunal monolayer system, both isoforms 





monolayers this isoform was expressed at similar levels as Cftr. However, as both isoforms show mRNA 
expression, and protein measurements are made difficult by the lack of useful antibodies and the multi-
membrane spanning domain nature of the channels, future genetic knock-down is the next best method to 
assess which isoform is involved in our system.   
 These two classes of chloride channel are regulated by two interconnected signaling pathways; 
CFTR is regulated by phosphorylation by PKA—a cAMP dependent enzyme—while CaCCs are true to 
their name and regulated by increases in [Ca2+]i. The activation of only CaCCs by muscarinic signaling 
and both by cholinergic signaling indicates that the nicotinic pathway may be regulating cross-talk 
between intracellular calcium and cAMP signaling. 
 As both muscarinic and nicotinic receptors are known to increase [Ca2+]i, we were interested in 
determining 1) where the potential cross-talk occurs relative to the increase in intracellular calcium and 2) 
if there was a quantifiable increase in [Ca2+]i in cholinergic-stimulated monolayers compared to ones 
stimulated by bethanechol alone. Control Caco-2 monolayers expressing both the M3 receptor and the 
cytosolic calcium sensor GCaMP6s showed bethanechol stimulated calcium release was not altered by the 
co-application of nicotine, and nicotine alone was not sufficient to stimulate a detectable increase in 
calcium in this system. This is unexpected as the nicotinic receptors are commonly considered ligand-
gated cation channels, though specific subunits modify the exact selectivity for calcium and determining 
the specific composition of each channel is difficult due to endogenous heterogeneity and the difficulty in 
detecting small differences between subunit isoforms91–95,147. As we did not observe a synergistic increase 
in calcium upon nicotinic stimulation compared to muscarinic alone as expected, we concluded that the 
nicotinic receptors could not be acting through their channel function to increase Isc, but through a new, 
poorly described receptor-mediated signaling pathway. Based on our observations regarding nicotinic 
activation of CFTR and literature indicating nicotinic-induced Isc in mouse trachea is sensitive to the PKA 
inhibitor H-89, we hypothesize that nicotinic receptors could be directly increasing cAMP in response to 
nicotine and carbachol148,149. This effect could possibly be mediated through Gs signaling based on recent 





Recent data has shown that nicotinic signaling in the rat colonic epithelium is mediated through 
PKC to regulate the Na+/K+-ATPase rather than through cation conductance101,148. While the pump is not 
the rate-limiting step in generating potassium current, it does generate electrical current as a result of 
electrogenic exchange of 3 sodium ions for 2 potassium. This helps maintain the electrical state of the cell 
and provide some driving force for chloride secretion, even if it’s not the primary protein involved in that 
function. Links between nicotinic ligand-gated cation channels and non-channel related functions are a 
very new concept, thus little is known about the signaling mechanisms involved150–152. However, we can 
agree that signaling independent of the nicotinic receptor’s ion transport capabilities is involved as our 
own data demonstrates a lack of cation-mediated effect through nicotinic signaling relating to chloride 
secretion.  
 Intracellular calcium is known to be the major signal mediating cholinergic-induced anion 
secretion and barring a nicotinic contribution, the muscarinic-induced release of ER calcium stores into 
the cytosol is the primary contributor. Knowing this, chelation of intracellular calcium with membrane 
permeable BAPTA-AM was hypothesized to abolish cholinergic- and muscarinic-induced Isc as our 
understanding of the pathway resulting in cholinergic anion secretion depends on the increase in cytosolic 
calcium. Surprisingly, BAPTA-AM only partially reduced Isc in CCh and BCh stimulated monolayers. 
Validation of the BAPTA-AM conditions using calcium imaging in Caco-2 M3R/GCaMP6s monolayers 
indicated that this residual Isc is not due to incomplete chelation, but rather it is likely the result of a 
pathway activated upstream of ER release of calcium stores.  
As intracellular calcium is at least partially involved in regulation of cholinergic secretion and the 
cAMP pathway needs to be activated to in turn activate CFTR in the presence of nicotinic signaling, it 
stands to reason that nicotinic signaling may regulate a protein or enzyme involved in calcium-to-cAMP 
crosstalk. The adenylyl cyclases are a family of enzymes that catalyzes the ATP to cAMP reaction. Many 
of isoforms are calcium sensitive and of the three isoforms known to be calcium activated129,132, only AC8 
had detectable expression in the mouse jejunal monolayers. Very little is known about AC8, but it has 





pathway124–127,130,131,153. As a result, analysis of the contribution of extracellular calcium on cholinergic 
secretion was the next step.  
There are links in the literature tying ACs to anion secretion, ACs to extracellular calcium, and 
extracellular calcium to anion secretion. We hypothesized that part of the nicotinic regulatory mechanism 
of muscarinic chloride secretion involved nicotinic regulation of the extracellular calcium (SOCE) 
pathway. In overexpression systems, AC8 has been shown to be activated by CRAC-mediated calcium 
entry to generate cAMP and induce chloride secretion124–128,130,131,153,154. SOCE has also been implicated in 
a broader way in secretion in a few other tissues such as the sweat gland and salivary gland122,123,155–157. 
Store-operated calcium entry (SOCE) is a mechanism by which depletion of ER calcium levels leads to 
dimerization and re-localization of ER membrane protein and calcium sensor STIM1. These dimers bind 
to the plasma membrane calcium channel ORAI1, allowing extracellular calcium to enter the cytosol135–
142. In sweat glands, a polarized, secretory epithelium with many of the same mechanisms regulating 
chloride secretion observed in the intestinal epithelium, SOCE is an apical process with a role in chloride 
secretion123. 
However, in practice extracellular calcium only had a moderate effect on maximum Isc in the 
jejunal monolayers and only loss of the basolateral pool of calcium had an effect at all. This indicated that 
1) chelation was incomplete, 2) SOCE is basolateral rather than apical in the intestinal epithelium, or 3) 
SOCE was uninvolved. SOCE has not been investigated thoroughly in the intestinal epithelia, but there is 
some data indicating a basolateral calcium pool being involved in SOCE in this population143. 
Interestingly, though it has not been linked to SOCE directly, the role of serosal calcium in intestinal 
secretory function is not a new concept, though molecular identities and functions that have since been 
identified need to be linked to the previously described observations30–32.  
While extracellular calcium had very little effect on the first phase of the Isc response, chelating 
calcium from the basolateral pool completely abolished the second phase of secretion. This data 
reinforces the observations made using the potassium channel inhibitor, separating cholinergic anion 





Unexpectedly, the second phase also showed that stimulation with carbachol after inhibition with 
either of the chloride channel inhibitors resulted in a faster return to baseline and reduced total secretion 
quantified as AUC, while monolayers stimulated with bethanechol were unaffected indicating that 
nicotinic signaling also has a role in the second phase. Based on the fact that the presence of nicotinic 
signaling reduced total secretion and decreased the time it took to return to baseline, it is possible that 
nicotinic signaling is involved in the down-regulation of cholinergic anion secretion.  
Further studies of the contributions of the apical potassium channel, basolateral calcium pool, or 
nicotinic signaling to the second-phase and/or down-regulation of cholinergic anion secretion would be 
performed using agonists and antagonists of the known down-regulation pathways, such as EGFR as the 
most upstream activator and select downstream targets such as PI3K, ERK, and p38 which are involved in 
several independent pathways of downregulation of cholinergic secretion. 
This novel two phase paradigm for cholinergic signaling brings up more questions than it 
answers, but at the same time demonstrates how a system or function we believe we completely 





VII. Co-culture of mouse jejunal enteroids with the enteric neurons 
and glial cells of the sub-mucosal plexus (SMP) 
A. Background 
Interconnected biological systems are constantly influencing each other in order to maintain 
homeostasis. Under normal, homeostatic conditions, cells do not function at either their minimum or 
maximum capacity; whether the function is cell growth and division, secretion, absorption, tone, or 
signaling. This allows for the cells and systems to respond to stress or environmental stimulus. This 
responsiveness is necessary for organisms which do not exist in a static equilibrium, but instead flux 
between states: fed and fasting, resting and active, healthy and ill. The cells of the enteric nervous system, 
present in the sub-mucosal plexus and the cells of the intestinal epithelia have been shown to exert such 
reciprocal communication; neurotransmitters secreted from the epithelia, such as serotonin, act on the 
neurons to stimulate neuronal transmitters, which then alter epithelial function.  
Current models of the intestine focus on the extremes of isolated cell populations or entire tissues. 
Isolating cultures completely removes the constant, modulating effects of other cell populations but 
allows for systematic interrogation of a specific cell type in a highly controlled environment. Whole tissue 
or whole organism work has multiple cell populations involved, making it difficult to determine which 
cell populations and/or signals are responsible for a specific response. It becomes a complicated question 
of which comes first, the chicken or the egg, only there is on the order of tens—if not hundreds—of 
potential components. 
There are pathologies in the gut which affect more than just the intestinal epithelial cells. Up to 
half of the secretion from major diarrheal disease models, such as cholera and rotavirus, involve the 
contributions of the ENS16,158,167–175,159–166. Without understanding how both the neuronal and epithelial 
cell populations influence each other, a part of the pathophysiology of diarrhea and potential treatment 
remains unaddressed. We proposed to put together two defined models to better understand whole 





Intestinal enteroids are cultures derived from the crypts of adult intestine which maintain the 
capability to proliferate and differentiate into the various intestinal cell populations, including goblet 
cells, enteroendocrine cells, and enterocytes9,52,53,55,176. These cultures can be expanded indefinitely 
without becoming cancerous and used to assay various functions. Similarly, the sub-mucosal plexus 
(SMP) neurospheres used in culture are derived from the SMP of an adult mouse and consist of the 
neuroglial precursor stem cells, enteric nerves, and enteric glia65,66. These cultures can also be expanded, 
differentiated, and assayed for function65,66,177,178. Culturing these primary, adult derived neurons and glia 
with isolated intestinal epithelia will offer a tool to enhance the collective understanding of these two 
populations, how they affect each other in vivo, and model a more complex intestinal system178–183.  
B. Results  
1. Established SMP cultures can persist in enteroid-permissive conditions 
 Sub-mucosal plexus cells were isolated from adult Wnt1cre:tdTomato mouse (in which all neural 
crest-derived populations are tdTomato+) small intestine and purified by magnetic sorting for the CD45-
negative fraction to remove contaminating immune cells from the culture. Resulting neurospheres were 
grown in suspension in stem cell medium containing growth factors EGF, FGF, and GDNF (SCM+GF) to 
proliferate for one week before being plated adherently on coverslips coated with 50% diluted Matrigel in 
neuron differentiation media (stem cell medium, SCM) for 5-7 days. Isolated small intestinal mouse SMP 
neurospheres, plated adherently and allowed to differentiate before being transferred to enteroid-
permissive conditions as published by Sato et al9,11,55,184 were able to grow equally as well as cultures that 
remained in neural differentiation media (SCM) (Methods). Cultures plated in the presence of mouse 
jejunum enteroids showed no morphological difference to those in Sato media alone or cultures remaining 
in SCM. Enteroids and SMP cultured on coated coverslips without the other population served as 





Unfortunately, though the cultures grew well together over time (Figure 16A, B), the co-culture 
system has a limited lifespan due to the limitations of the 3D enteroid culture. Without breaking open and 
passaging the enteroids to remove dead cell debris from the mouse enteroid cultures, the enteroids have a 
maximum culture lifespan of approximately one week in standard conditions. When passaged as a co-
culture, both cell populations persisted. However, the SMP population lost all projections and was unable 
to regenerate them to the same extent under culture conditions despite survival of the population (Figure 
16C). It was eventually determined, that while the enteroid-permissive condition was permissive to 
neuronal survival and growth, it was not enough to initiate differentiation and neuronal projections as 
neurospheres plated directly in Sato media likewise were unable to produce neuronal processes, though 
the cells neither died nor proliferated. As such, future co-culture protocol includes at minimum a five day 
pre-differentiation period for the neurons once they are plated adherently before being co-cultured with 































































Co-culture of the wnt1-cre:tdTomato SMP and mouse jejunum enteroids in Sato 
media at A) two days post co-plating and B) 5 days post co-plating. C) SMP 
neurosphere grown for three days in co-culture and imaged 3 days after co-culture 
passage (total days in co-culture = 6). Neurospheres were never able to re-establish 
projections while in co-culture with the enteroids. Scale bar = 100μm. D) FIS assays 
performed on co-cultures from SMP isolations plated and pre-differentiated 6 days or 
18 days before co-culture with the enteroids (3-4 days) in ND Sato media. The SMP 
cultures co-plated at the end of the differentiation process showed no influence on the 
co-cultured enteroids while the less-differentiated SMP cultures had an inhibitory 
effect on forskolin-induced swelling in the enteroids. Bars indicate SEM, some error 

































































































enteroids did not prevent further development. The co-cultures themselves then have a limited lifespan of 
3-5 days before cell death begins to overtake the enteroids and affect the SMP culture. For consistency, 
most physiological assays of the SMP and co-cultures were performed 2-3 days after co-culture. 
While the enteroids are maintained in a proliferative state throughout the culture lifespan, the 
SMP neurons are undergoing a long differentiation process. The normal differentiation protocol for the 
SMP cultures is 21-24 days in SCM. Based on imaging of SMP cultures grown side-by-side in SCM and 
Sato media, the Sato media appears to support the continued differentiation of the SMP with and without 
the presence of the enteroids. Whether this steady differentiation process has an effect on the co-culture 
system was investigated with a pair of FIS assays performed on co-cultures that were co-plated at the 
earliest possible time point (N6) and the latest (N18).  It was shown that the older SMP cultures did not 
exert an effect on the forskolin-induced secretion of the enteroids while the younger cultures do appear to 
have a basal suppressive effect on forskolin-induced [5μM] enteroid secretion (Figure 16D). 
Additionally, the younger SMP cultures were more motile, actively moving and generating processes 
towards nearby enteroids—most notable in the processes reaching across z-planes—while the older SMP 
cultures did not demonstrate any morphological or motor changes in response to enteroids plated nearby 
or even directly on top of the SMP, remaining steadfastly within the original z-plane and networks (data 
not shown). As a result, most experiments were performed with SMP cultures that were 7-14 days pre-
differentiated.  
2. SMP effects on enteroid secretion depends on the differentiation status of the SMP 
culture when co-cultured 
 Basal functions of the epithelial barrier such as transport have been shown to be subject to 
modulation by the ENS171,173,192,174,185–191. However, specifics of function such as effects on basal or 
stimulated secretion and specific transmitter effects vary between segments and species. 
The primary transport assay of the 3D co-cultures is the FIS assay12,13,20,67,68. In short, 3D 





enteroid. This change in volume can be observed post-stimulation (ex. 5μM Fsk) and imaged using any 
imaging system that supports live cell time-lapse imaging, though an incubation chamber for longer 
studies may be necessary as well. The increase in cross-sectional area over time of each enteroid is then 
measured, normalized, and averaged to produce a summary of basal and stimulated chloride secretory 
function. 
 The presence of the SMP in co-culture with the enteroids for two days prior to the FIS assay 
showed no significant effect on basal behavior of the enteroids pre-stimulation (Figure 16D). The basal 
activity of the SMP in these conditions has neither a stimulatory nor inhibitory effect on basal secretory 
behavior of the enteroids. The SMP culture was not affected in any way beyond the signaling of the 
enteroid culture, showing that at baseline and under initial co-culture conditions, enteroids have the same 
secretory behavior over time with and without the SMP.  
Stimulation with forskolin caused chloride secretion that resulted in a significant increase in 
cross-sectional area of enteroids cultured in Sato media both with and without the SMP for 3-4 days. The 
forskolin-induced response was significantly reduced in the presence of SMP cultures that were not fully 
differentiated at the time of co-culture. This may be a result of 1) the aged SMP cultures may not signal as 
strongly and the weaker signal is not detected by the enteroids, 2) the aged SMP cultures have a different 
signaling profile, or 3) the aged SMP cultures are not plastic enough to respond to the enteroids and 
establish the required connections to signal properly. Observations of plated SMP cultures with and 
without the enteroids indicate that plasticity may at least partially explain the difference, as ‘young’ SMP 
cultures plated with enteroids exhibit extensive, 3D branching patterns when within an undefined distance 
of an enteroid that paired ‘young’ SMP cultures plated without enteroids do not. ‘Aged’ SMP cultures do 
not exhibit much 3D branching over the same period of time, regardless of the presence or absence of the 
enteroids. This can be observed using an inverted microscope where SMP cultures either reside entirely in 






3. 2-Dimensional co-culture Conditions 
Due to the inability of enteroids grown in Sato media to generate monolayers, a different media 
condition (minimal media) was generated that permitted mouse enteroids to be grown to confluence on 
Transwell filters (Table 1, Figure 1, Figure 2). Due to limitations of the 3D co-culture model, designing 
a 2D co-culture model was a logical next step once the mouse enteroids were able to be grown as 
confluent monolayers.  
Attempting to culture the SMP in the monolayer media condition led to loss of SMP viability 
within 14 hours (Figure 17B). Subsequent re-building of the previously successful media condition 
(Sato) using permutations of the removed components, gave rise to four combinations that led to SMP 
culture survival longer than 72 hours (Figure 18C-F). These four conditions were then tested for 
monolayer permissiveness, where two of the four conditions formed confluent monolayers within ten 
days while the other two conditions did not (Figure 18G). The two conditions that were deemed 

















































SMP Neurons grown in A) SCM for 6 days (scale bar = 200μm) and B) 14 hours post-condition switch to the monolayer-
























4. Effects of enteroid media composition on SMP culture identity 
While determining the effect on secretory function of the different media conditions, the effect of 
those conditions on the differentiation of the SMP was also being investigated. In particular, the effect of 
the media condition on the sub-type of SMP neurons in culture. To do this, SMP cultures were grown in 
either of the two monolayer permissive conditions (+GS and +N) and then stained for either choline-
acetyltransferase (ChAT) or vasoactive intestinal peptide (VIP), markers of the two most prominent 
A-F) SMP cultures that survived 72 hours in culture after media was changed to the indicated conditions. Scale bar A, 
D-F = 100μM, B-C = 200μm. G) TER of enteroid monolayers plated in SMP-permissive conditions. The dotted line 
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neural sub-populations of the SMP. Together, these two markers should account for almost all of the SMP 
neurons, are almost mutually exclusive markers, and in the mouse SMP, VIP should stain 50-60% of all 
neurons while ChAT stains 40-50%174,193,194.   
After 6 days pre-differentiation and 3 days in either of the monolayer-permissive media 
conditions, it was determined that the SMP cultures co-expressed far more ChAT and VIP than expected 
in both conditions (Figure 19A and B). The discrepancy in ChAT and VIP expressing populations in 
culture versus published observations in tissue led us to question 1) the specificity of the antibodies and 2) 
the possibility of artificial select by culture conditions as our findings indicated that almost 100% of the 
SMP populations we had in culture co-expressed ChAT and VIP when the two markers should be 
mutually exclusive.  
Percent of specific neuron sub-populations in 
SMP cultures grown in the indicated media 
condition for 3 days after 6 days of pre-
differentiation and stained for A) VIP and B) 
ChAT. Number of cells counted (Hoescht+) is 
indicated at the base of each bar. C) Summary 
of % ChAT expression in HuC/D+ neurons in 
a ChAT-tdTomato transgenic mouse line. 
>100 random fields per mouse across all three 
small intestinal segments. n indicated in the 











































Figure 19: Summary of ChAT expressing 





5. ChAT+ neurons in mouse small intestinal tissue 
To determine whether this discrepancy with the literature was true or due to non-specific antibody 
staining, we isolated tissue from all three small intestinal segments from 3 adult littermate ChAT-
cre:tdTomato mice and stained with the well characterized pan-neuronal marker antibody HuC+HuD 
before counting the number of ChAT+ neurons in the mouse tissue. Surprisingly, the SMP showed greater 
similarity in the sections from the same mouse than across sections between littermates, though there 
were no significant differences in any of the populations of neurons examined (Figure 19C). More 
importantly, the transgenic ChAT marker was expressed in far fewer of the neurons than the antibody in 
culture showed, preliminary culture of ChAT-tdTomato neurospheres in monolayer-permissive conditions 
with the addition of Calcien Green-AM to indicate live cells indicated that ChAT expression was not as 
prevalent as the antibody indicated in previous cultures (data not shown) leading to the conclusion that 
both antibodies were likely non-specific as they gave similar results in culture and the results of the 
culture analysis were artificially high rather than artificial selection in culture for a co-expressing sub-
type. Due to continued technical difficulties in staining with the ChAT and VIP antibodies, the final 
composition of the SMP cultures remains unknown, but due to the variability in mouse tissue expression 
(Figure 21C), it is likely that variability in culture will have less of an effect on epithelial function than 
believed unless an entire sub-population is completely missing. 
6. ChAT+ epithelial cells 
 The use of the ChAT-tdTomato mouse to generate clear ChAT+ populations for imaging led to 
the unexpected observation of a rare, ChAT+ epithelial cell population. The rarity of the population led us 
to hypothesize that the population was either the CHGNA expressing enteroendocrine population or the 
DCLK1 expressing tuft cell population. Both populations serve sensory and communication purposes but 





ChAT-tdTomato mouse jejunum were stained with either the EEC marker CHGNA or the Tuft cell 
marker DCLK1 and imaged. We found that ChAT-tdTomato expression could be found in the same cells 
that stained positively for DCLK1 and independent of CHGNA, indicating that the ChAT+ population 
was tuft cells (Figure 20). A literature search confirmed the presence of this ChAT+ epithelial population 
by both imaging using an even more extensive array of Tuft cell and Enteroendocrine cell markers and 
single-cell RNAseq97,203,204. The ChAT+ population persisted in enteroid and monolayer culture, with 
Chat being expressed in both ND and DF cultures by qRT-PCR and matching our previous observation of 
the tuft cell marker Dclk1 being expressed in both ND and DF cultures.  
7. FIS Assay in SMP permissive conditions 
 As there was no conclusive, significant difference observed in the two SMP-permissive media 
conditions in regards to SMP identity using the methods we tested, we proceeded to test for a possible 
functional influence of the media conditions on the FIS assay. In initial experiments, basal behavior was 
unaffected and forskolin [5μM]-induced swelling exhibited a significant increase in cross-sectional area 
regardless of the conditions used or the presence of the SMP (Figure 21A). There is what appears to 
trending decrease in the forskolin-induced response in enteroids cultured minimal media+NGF with the 
Epithelial ChAT (red) is expressed in A) Tuft (green, DCLK1+) cells, not B) Enteroendocrine (green, 
ChgnA+) cells in the mouse jejunum. Adult ChAT-tdTomato jejunum. Nuclear marker Hoescht (cyan).  






















































SMP compared to the +GS+SMP co-culture condition or in NGF without the SMP present (NGF+SMP: 
26.31% ± 5.51% vs GS+SMP: 42.16% ± 4.6% and NGF-SMP: 40.87% ± 6.17%), but it does not reach 
significance, likely due to the small n of the experiment. 
A) Preliminary FIS assay using enteroids co-plated for 2 days with or without the SMP (N10+E2) in either media 
+Gastrin and SB202190 or +NGF normalized to the area of the enteroid at t=0 for control and post-forskolin [5μM] 
addition to account for normal variation in enteroid size. Forskolin induced a significant increase in cross-sectional 
area in all conditions.  B) Expanded FIS assay using enteroids co-plated for 2 days with or without the SMP (N10+E2) 
in +GS media condition normalized to the area of the enteroid at t=0 for control and t=0 when forskolin is added to 
account for normal variation in enteroid size. Enteroids respond with a significant increase in cross-sectional area in 
response to forskolin (p<0.0001) regardless of the presence of the SMP or not, and there is no difference between 
responses in the cultures that were co-plated with the SMP and the enteroids plated alone. The SMP also has no effect 






































 Due to the apparent trending decrease in FIS in the +NGF+SMP co-cultures and the fact that the 
+GS condition is almost identical to the Sato condition (minus one component) while the +NGF condition 
is more dis-similar (minus three components and plus one new component), we decided to do a more 
extensive test with the GS condition to confirm the secretory behavior of the co-culture. As expected 
based on previous observations, in a larger population the presence or absence of the SMP had no effect 
on FIS in the enteroids (Figure 21B). Continued use of the +NGF condition would have required 
complete re-characterization of the enteroid cultures. Though it is interesting that something about the 
A) Cartoon schematic of the proposed co-culture system. B) Images of the base of the Transwell filter and the base of 
the well immediately below the same location five days post-seeding. Scale bar = 200μm. C) Average TER of mouse 
jejunum enteroids seeded on dual-coated Transwell filters with or without the SMP in the two permissive conditions. 
The dotted line indicates when monolayers are approximately confluent. SEM indicated by error bars, bars may be 



























































+NGF culture condition changed either the SMP population, the enteroid population, or both to lead to a 
possible effect on anion secretion, determining the cause of this effect was beyond the scope of this 
project. 
8. Assembly of 2D co-culture system 
Once conditions permissible to all components of the proposed co-culture system were 
determined, the next step was to attempt assembly of the culture. Since the SMP culture required pre-
differentiation, and mouse enteroids were shown to be incapable of growing to confluence when seeded 
on the inverse of the Transwell filter (data not shown), SMP cultures were seeded on the bottom of 
Transwell filters that had been pre-coated on the top with 200μg/mL rat tail collagen type 1 (for the 
enteroids) and double coated with 1mg/mL rat tail collagen I and 20μg/mL fibronectin on the bottom (for 
the SMP). After adhering to the inverted filter for 45 minutes-1hour at 37°C, the filters were gently 
flipped into pre-warmed (37°C) SCM and allowed to differentiate.  
Both the filter and the base of the well were imaged over several days to determine the efficiency 
of SMP adherence to the filter over time (Figure 22B). After differentiating 7 days, mouse jejunum 
enteroids were seeded in either of the two permissive media conditions (+GS and +NGF) and TER was 
monitored (Figure 22C). As there was no difference in TER or in the time for the monolayers to become 
confluent regardless of the condition used or the presence of the SMP (Figure 22), the decision was made 
to focus on the +GS condition for future experiments. As there were no observed functional differences in 
the metrics we were interested in, it was decided to test the more-similar condition to reduce the amount 
of re-characterization necessary.  
9. 2-Dimensional co-culture of the ENS with mouse jejunum enteroids: SMP behavior 
 Once culture conditions and protocol permitted successful co-culture of the ENS and mouse 





the SMP neuron projections reach through the filter pores towards the epithelial monolayer or does the 
filter remain as ‘dead space’? 
Two experiments were done to address these questions. First, co-cultures plated on 1.0μm pore 
Transwell filters (Millipore)--to better facilitate neural ‘reaching’ if it does occur—were plated and grown 
to confluence before being fixed and imaged for any slender projections extending into the 10μm thick 
filter. While not common, in multiple locations on several filters, projections did indeed reach through the 
pores towards the monolayer (Figure 23A).  
The second experiment was to plate the enteroid monolayer in direct contact to the SMP culture, 
similar to how the 3D cultures were generated, but without the layer of Matrigel in between the two 
populations. Direct plating of the enteroids on the SMP led to rapid loss of projections from a majority of 
A) SMP neural projections ‘reach’ towards enteroid monolayers on a volumetric rendering of a z-stack obtained on confocal.  
Arrows indicate neural projection ‘reaching’ across the Transwell filter. Image of the SMP 3 days post-enteroid plating in 
+GS on B) on the opposite side of the Transwell filter and C) on the same side of the Transwell filter. SMP cells in direct 
contact with the enteroids have largely begun to lose projections within three days of co-culture while the SMP cells on the 






























































the cells of the SMP culture that never recovered (Figure 23B, C).  So while the neural projections do 
indeed reach towards the epithelial layer through the Transwell fitler, plating the SMP in direct contact 
with the epithelia is detrimental to SMP survival. The final co-culture protocol consisted of SMP plated 
on the bottom of a double-coated Transwell filter with the enteroids plated on the single coated top after 
5-7 days predifferentiation and transfer to the +GS medium condition until TER was determined to be 
confluent.  
It is interesting to note that co-culture with the enteroids appears to have an effect on the survival 
and lifespan of the SMP cultures. Though there are no SMP only controls in the co-culture conditions, it 
is known that SMP cultures in the normal SMP differentiation condition (SCM) have a culture lifespan of 
about 22-24 days before the majority of the culture is dead/dying. In monolayer co-culture experiements, 
it was observed that neurons are still morphologically healthy at SMP culture day 34 (co-cultured with 
enteorid monolayers for 27 days). This unexpected finding is definitely a benefit for future studies of the 
co-culture as the 24-day lifespan of the SMP is no longer a limiting factor and investigation into the cause 
of SMP persistence may also help SMP research by both allowing the SMP to be cultured for longer and 
offering insight in to physiological signaling between the two populations and the SMP survival 
pathways. 
10. The presence of the SMP in 2D co-culture leads to an increase in stimulated short-
circuit current (Isc) 
Mouse jejunal enteroid monolayers plated in +GS medium concurrently with enteroids co-plated 
with the SMP on the bottom side of the filter on SMP differentiation day 7 (E15 v N22+E15) were 
mounted in an Ussing Chamber/Voltage Clamp to assess electrogenic ion transport. Previous FIS assays 
indicated that the SMP had no effect on either basal or stimulated secretion when cross-sectional area of 
the 3D enteroids was used as the metric. This was in contrast to the literature describing a strong 
influence of the ENS on intestinal secretion after exposure to several different agonists, including 





Basal Isc appears to be increased in the co-cultures compared to passage and age matched 
enteroid-only monolayers (0.36μA/cm2 vs 4.18 ± 1.63μA/cm2) but data is inconclusive without a greater 
number of samples (Figure 24B). Similarly, stimulation with 5μM forskolin appears to cause an increase 
in peak Isc (8.11μA/cm2 vs 15.20 ± 2.60μA/cm2, Figure 24C) that does not seem to fully resolve after the 
addition of CFTRinh-172 [20μM] (determined as the average of the last ten time points recorded; -



































A) Short-circuit current traces of three co-cultures and one control culture and B) Average maximum peak in response to 
stimulation with 5μM Fsk. Co-culture with the SMP appears to increase stimulated Isc in response to 5μM forskolin. 
Atropine has no effect on forskolin-induced Isc post-stimulation with Fsk and the inhibitor CFTRinh-172 inhibits Fsk-
induced Isc.  B) The basal Isc exhibited in both control and co-cultured monolayers. Baseline secretion was determined as 
the average of the ten time points immediately prior to addition of forskolin divided by the area of the monolayer.  C) Max 
peak Isc after forskolin [5μM] stimulation in both control and co-cultured enteroid monolayers.  D) The difference in the 
average Isc of ten time points 200s after the addition of CFTRinh-172 compared to the average of ten time points 
immediately prior to CFTR inhibitor addition. The drop in Isc in the control monolayer is about equal to the Fsk-induced 
increase while the reduction in co-cultured monolayers is less.  E) Average of the final ten time indicates that inhibition of 
CFTR is not enough to return Isc to baseline in monolayers co-cultured with the SMP. Bars represent mean ± SEMs. p-







































































during secretion (Figure 24D).  The late addition of atropine had no apparent effect on the stimulated 
current or the resolution of Fsk-induced Isc, showing that the increase in forskolin-induced secretion is not 
due to SMP release of acetylcholine.  
Overall, the addition of the SMP culture appears to have increased the short-circuit current (Isc) in 
response to forskolin [5μM] in a manner similar to tissue behavior as documented in the literature, this is 
in contrast to the observations made using the FIS assay in 3D co-cultures in the same media condition. 
Whether this is due to the longer co-culture time for the monolayers (15 days opposed to 2-4 days) or 
some other factor we do not yet know and investigation fell beyond the scope of this project. 
C. Discussion 
 The inclusion of the SMP component of the ENS in culture jointly with the epithelial enteroids 
demonstrates not only that the two cultures can persist together in appropriately permissive conditions, 
but also that there is a functional influence exerted on the epithelia by the presence of the SMP. The 
development of this co-culture method opens the door to more physiologically accurate studies of both 
intestinal function and pathophysiology. Though its composition appears to be highly variable, it is 
without doubt that the SMP plays an important role in monitoring and influencing the intestinal epithelia.   
 The variability in tissue samples taken across the entirety of the small intestine and the technical 
problems with antibody staining limits the characterization of the SMP component of the current model 
which is an unfortunate limitation that may require single cell sequencing to ultimately address if the 
immunofluorescence capabilities remain limiting. Despite this major, unresolved component, the SMP 
cultures were able to exert a modulatory influence on the enteroid monolayers with relatively small 
numbers. Further optimization of the SMP isolation and culturing techniques is undoubtedly required to 
get a better measure of the scope of functional coupling the two systems undergo, but even this initial 
method is able to demonstrate a functional effect on anion secretion similar to that observed in intestinal 
tissues exposed to neuronal inhibitors and a known secretogogue. This system then, provides a first step 





The preliminary ion transport data acquired in the monolayers does offer insight to intestinal 
physiology already. The co-culture demonstrates an increase in baseline Isc, indicating a role of the SMP 
in baseline secretion resulting in higher basal Isc in the presence of the SMP. Determining whether this is 
a permanent change due to the long-term co-culture or short-term change maintained by constant 
signaling remains unknown but investigation will offer insight to the differences in development and 
identify in culture versus tissue models.  
Like in tissues, there is an increase in forskolin-induced Isc indicating a role of the SMP in cAMP-
induced Isc but there is also the fact that the CFTR inhibitor 172 did not fully abolish the Fsk-induced Isc 
in the co-culture model. Thus the SMP facilitates not only a potential increase in CFTR-mediated current, 
but it is likely that a second pathway is activated in the presence of the SMP. The identity of this pathway 
can be determined by testing the effects of other inhibitors such as the CaCC inhibitor A01 on Fsk-
induced Isc in the co-cultures. The lack of a significant effect by atropine indicates that whatever signaling 
is responsible for the SMP effect on forskolin-stimulated secretion, it is not likely to be SMP release of 
acetylcholine. 
Another interesting thing about this experiment is that as far as we know, forskolin does not on its 
own stimulate paracrine signaling from the neurons. That is, forskolin itself does not stimulate neuronal 
secretion to signal to the epithelium which then causes an increase in Isc. Thus the SMP effect on 
epithelial secretion is caused by either 1) basal SMP signaling behavior and effects on the epithelium or 
2) a secondary signal from the epithelium being released in response to forskolin and having an effect on 
the SMP half of the culture which then signals back to the enteroids to change secretory behavior.  
As forskolin does not itself stimulate neuronal signaling, a follow up experiment using a stimulus 
that targets the SMP culture resulting in an SMP-induced effect on the epithelium is still required. The 
difficulty in designing such an experiments is the diversity of the intestinal epithelium. Even the ND 
enteroid cultures may be able to sense and respond to most of the agonists known to cause a neuronal 
response that results in signaling that could stimulate ion transport, so an alternative readout may be 





While data is only preliminary, it is promising that the monolayer co-cultures closely mimic 
tissue behavior in these initial tests. Should the co-culture system behave as expected, we would expect 
not only forskolin-induced secretion to be increased, but application of secretory pathogens and toxins, 
such as cholera toxin and rotavirus, to co-cultures should also result in higher Isc compared to enteroid 
monolayers alone. From there, the model could be used to study the pathology of secretory diseases, 
identification of pharmacological treatments for disease, or even the basal physiology of the SMP-
epithelium cross-talk.  
 Despite requiring further optimization, the system shows promise as a tool to further characterize 
intestinal physiology and pathophysiology, as even this non-optimized system displays the characteristic 
increase in anion secretion in preliminary experiments. This proves its use in further studying diseases 
that have a neuronal component modulating pathophysiology such as diarrhea.   
Should further characterization indicate the co-culture system as an acceptable replacement, 
studies of the SMP-epithelium cross-talk in physiology and pathophysiology will be possible without the 
confounding factors of immune and muscular populations present in the tissue. As demonstrated earlier in 
this work, the presence of additional populations and the assumptions made because of them can mask 
important physiology, leading to inaccurate conclusions and perpetuated misunderstanding of physiology. 
These assumptions can then influence or even limit clinical applications, our understanding of disease, or 





VIII.  Final Comments 
 The enteroid culture system has a wealth of potential in moving forward studies of epithelial 
biology, but it—like any other model—has its flaws and drawbacks. Here we attempted to address several 
of those limitations to create a more physiological model and in the process, observed and began to define 
entirely new aspects to a process previously considered understood.  
 The confirmation of a previously defined differentiation protocol in addition to the modified non-
differentiation conditions provides a more polarized system than previously defined for the mouse 
enteroids. This system can be used to separate the crypt and villus populations for studies of 
differentiation, regeneration, transport, infection, and other physiological functions. The intestinal crypt 
and villus display distinct functional behaviors, and being able to reproducibly culture the two systems is 
an important ability that the mouse enteroid community lacked for many years.  
 The second development described significantly increases the usability of the mouse enteroid 
system by defining a reproducible method for generating confluent monolayer cultures of the mouse 
enteroids. Previously, studies were limited to what assays could be performed in the 3D enteroid cultures, 
and the stochastic nature of these cultures for many metrics such as gradients for nutrient, infection, or 
drug exposure to the enteroids made analysis of the resulting data difficult in some cases. Even physical 
considerations such as greater stiffness of the Matrigel matrix surrounding enteroids earlier in the culture 
life or enteroids being located more interior in the Matrigel dome compared to enteroids plated towards 
the edge of a culture brought up questions about the variability and significance of assays like the FIS 
assay where greater stiffness will likely expert a greater force suppressing the swelling used as a metric 
for secretion, this introduces an unquantified variable to FIS analysis that is ill-defined. To reduce 
variability in results and expand the potential applications of the system, monolayers will be a powerful 
tool.  
 Enteroid monolayers proved their usefulness when control experiments both recapitulated 





induced secretion hidden by the standard protocols used to separate epithelial function from residual 
neuronal input. The system proved its usefulness as a strictly epithelial system, offering greater 
understanding of epithelial biology separate from the underlying populations, something important for not 
only understanding the system in health, but also necessary for untangling the course of infection and 
disease and ensuring that the proper populations are targeted for treatment. There are many basal and 
pathological functions of the intestinal epitheliumio in response to cholinergic signaling, calcium 
signaling, and apparently the combination of the two. Not only has the enteroid monolayer system 
identified a series of new pathways and signaling applications, but it provides a platform for further 
investigation.  
The novel two phase paradigm for cholinergic signaling proposed brings up more questions than 
it answers, but at the same time demonstrates how a system or function we believe we completely 
understand may in fact be far more complicated and have hidden contributors. This is important to 
recognize not only for the contribution to basic science of correcting a misunderstood signaling pathway, 
but the widespread use of the muscarinic pathway to induce secretion in secretory epithelia may indicate a 
more widespread application of the nicotinic contribution in other secretory cell types as well. The 
pathways previously uncharacterized may be masking disease mechanisms or potential therapeutic 
targets. There may be genetic variation that was having previously unexplainable effects. If we as medical 
professionals do not understand how the body functions when healthy, it is impossible to adequately 
diagnose, study, or treat disease. That there are widespread assumptions regarding cholinergic-induced 
secretion, potentially in more secretory systems than the intestine alone, reveals an oversight in epithelial 
biology that could later influence clinical applications. 
The previously undefined nicotinic component to cholinergic intestinal secretion opens the door 
to identification of not only potential disease and therapeutic targets in the intestine, but also raises the 
question of muscarinic secretion in other secretory systems. Even more broadly, there is now the question 





there are other nicotinic functions such as the newly described signaling capabilities of the nicotinic 
receptors.  
 Further expanding the enteroid system as a co-culture model including the sub-mucosal plexus of 
the enteric nervous system offers another new model for the study of health and disease. It is known that 
there are diarrheal diseases with strong ENS components that epithelia-only models can not address either 
when studying the course of disease or developing treatment. Generating and characterizing a culture 
system that incorporates the SMP populations with the enteroid monolayers and demonstrating a 
preliminary functional influence of the co-culture compared to enteroid monocultures offers a promising 
solution to this limitation. The largest drawback is the time intensive protocol to generate the primary 
SMP cultures and the contributing factor of the harsh protocol meaning that several mice are needed to 
isolate enough cells for a single set of experiments.  
 Overall, the development and characterization of both the monolayer culture and the co-culture 
system strengthens the enteroid system by expanding potential assay methods and allowing for additional 
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